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   INTRODUCTION 
    INTRODUCTION 
In most developing countries, a traditional system are grounded in long 
standing cultural and spiritual values and is important that policy reflect and support 
this rather than attempt to replace tradition with science alone. Traditional health 
knowledge extends to an appreciation of both the materials and non material 
properties of plants, minerals and animals. 
Siddha medicine" means a perfect medicine. Siddha medicine claimed to 
revitalize and rejuvenate dysfunctional organs that cause the disease and to maintain 
three humours ideally. Siddhars who empowered the tremendous work in inventing 
siddha medicine before several decades, the knowledge was transmitted to each 
generation and different disciples written the evidence through palm scripts and in 
idol statues. 
A fundamental concepts found in siddha medicine is that of balance between mind 
and body. Siddha philosophy investigates into the fundamental principles of the 
world, life and its origin. The breaking of these interconnections of life is a 
fundamental source of disease. Treatment therefore are designed not only to address 
the locus of the disease but also to restore a state of systemic balance to the individual 
and his or her inner and outer environment 
The main effort in siddha medicine is using of metallic compounds, In the past 
many metallic preperations of siddha medicine and the practice were well flourished 
the best example is the idol statue of lord muruga architected by siddhar bogar in 
palani hills. The idols consist of nine different metallic preparations (navabhasanam) 
have high medicinal affinity. Since it is difficult to assay the therapeutic and toxicity 
of such drugs. Nowadays with the help of science, Toxicologist may overcome such 
difficulty, whether such preparation is neither safe nor threat. The ancient siddhars 
had their own methods of standardizing the drugs, by their spiritual knowledge. They 
detoxify the various metallic compounds in different purification methods and then 
processed into highly efficacious medicines  
“                      ” a moral note describes same as 
Paracelsus said "All things are poison, and nothing is without poison; only the dose 
permits something not to be poisonous."  
Aya veera chendhuram (AVC) a metallic preparation have high privilege in 
curing chronic pain in various degenerative diseases. In my study to determine the 
safety profile of aya veeera chendhuram and for global acceptance of our Siddha 
metallic formulations, I choose AVC for my dissertation to ensure its safety as pre 
clinically. 
  
 
 
 
 
 
 
 
   AIM AND OBJECTIVES 
AIM AND OBJECTIVES 
AIM 
The aim of this study is to evaluate the toxicological profile of Aya Veera 
Chendhuram. 
OBJECTIVES 
Based on the literature evidences, various sources of Ayam and Veeram have 
been collected and purified. At each stages of purification, compound analyses have 
to be done. After that, the purified Ayam and Veeram will be taken and used in the 
preparation of Aya Veera Chendhuram as per literature. Then, the finished product of 
Aya Veera Chendhuram is sent for elemental analysis to estimate the presence of any 
heavy metals and other organic and inorganic compounds. To analysis its safety, Aya 
Veera Chendhuram is subjected for acute and 28 days repeated oral toxicity 
evaluation under OECD guideline on rodents. 
Aya Veera chendhuram has been evaluated in the following aspects: 
1. Collection of relevant literatures  regarding Ayam and Veeram. 
2. Analysis the compounds present in before and after purification of 
Ayam and Veeram. 
3. Preparation of Aya Veera chendhuram as per textual method. 
4. Physiochemical analysis of Aya Veera chendhuram. 
5. Safety study of Aya Veera chendhuram on rodents. 
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þÐ ±øÄ¡ Á¨Ä¸Ç¢Öõ, ¿¢Äí¸Ç¢Öõ «§¿¸Á¡¸ì ¸ó¾¸õ §À¡ýÈ 
º¢Ä ¦À¡Õû¸Ù¼ý ¸ÄôÒüÚì ¸¢¨¼ì¸¢ýÈÐ. þÐ, ¾¡ÅÃ ƒ£Åô 
¦À¡Õû¸Ç¢ø º¢È¢¾Ç× ¸ÄóÐõ þÕì¸¢ýÈÐ. 
  «ñ¼§Å¡Î, «ôÀ¢Ã¸õ, ¸ó¾¢, ¸¢Ç¢ïº§Ä¡Î, ¦¸ÇÃ¢, ºùÅ£Ãõ, 
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¦Åñ¸Äõ, ¦Åû¨ÇôÀ¡¼¡½õ, ¬¸¢Â þ¨Å¸û «Âò¾¢üÌô À¨¸î 
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¨¸ôÒîÍ¨Å¸Ùõ, ¦ÅôÀÅ£Ã¢ÂÓõ Àº¢Ôñ¼¡ì¸¢, ¯¼ø ¯ÃÁ¡ì¸¢, ¯¼ø 
§¾üÈ¢ ¬¸¢Â ¦ºö¨¸Ùõ ¯Ç. 
 
«Âõ ÌÕ¾¢Â¢ý ¾ý¨Á¨Â §ÁõÀÎòÐõ. «Â ºõÀó¾ôÀð¼ 
ÁÕóÐ¸û ÁÄì¸ð¨¼ ¯ñÎÀñÏÅ¾¡ø «¨¾ ¾Å¢÷ì¸ ÓôÀ¨ÄÜðÊì 
¦¸¡ÎôÀÐÅÆì¸õ. ¯¼Ä¢ý ±øÄ¡ ¯ÚôÒ¸Ç¢ý ¦¾¡Æ¢ø¸¨ÇÔõ 
àñÎÅ¢ìÌõ. þ¾É¡øþÐ ¯¼ø §¾üÈ¢Â¡¸ ¦¾¡Æ¢ø ÒÃ¢¸¢ÈÐ. 
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§º¡¨À, Áó¾õ, ¸¡Á¡¨Ä, ÌýÁõ, Íì¸¢Ä¿ð¼õ, ¸Æ¢îºø, þ¨Å ¿£íÌõ, 
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  ÁüÚõ 'þ¨Çò¾Å÷ þÕõ¨À ¯ñ½ §ÅñÎõ' ±ýÈ Å¢¾¢Â¢¨É 
"±öôÒ¼ü ¸¢Õõ¨ÀÔñÁ¢ý" ±ýÛõÀÆ¦Á¡Æ¢Â¡ø «È¢¸. 
Íò¾¢ 
´Õ ÀÄõ «Âô¦À¡ÊìÌ ¬Ú ÀÄõ þÖô¨Àô âîº¡Ú Å¢ðÎ ¸¡¨Ä 
Ó¾ø Á¡¨Ä Å¨Ã ¦ÅÂ¢Ä¢ø ¨Åì¸ §ÅñÎõ. þùÅ¢¾õ ¬Ú ¿¡û ¦ºöÐ 
þÃñÎ ¿¡û º¡Ú Å¢¼¡Áø ¯Ä÷ò¾¢, À¢ýÛõ þ¨¾ô§À¡ø þÕÓ¨È 
¦ºöÐ, 25 ¬õ ¿¡û Ó¾ø ÀòÐ ¿¡ð¸û þ¨¼Å¢¼¡Áø §ÁüÀÊ 
º¡ÚÅ¢ðÎ, ¦ÅÂ¢Ä¢ø ¨ÅòÐô À¢ýÒ, º¡ÚÅ¢¼¡Áø þÃñÎ ¿¡û ¯Ä÷ò¾¢ 
¿£÷Å¢ðÎ ¸ØÅ¢ ±Îì¸î Íò¾¢Â¡õ. 
      §ÅÚ 
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§ÅÚ 
  «Âô¦À¡ÊìÌ ¿¡ÅüÀÆî º¡ü¨ÈãúÌõ ÀÊ Å¢ðÎ º¡Ú ÍñÎõ 
Å¨Ã ¦ÅÂ¢Ä¢ø ¨ÅòÐ ¸Ø×¸. þùÅ¢¾õ ¬Ú Ó¨È ¦ºöÂ Íò¾¢Â¡õ. 
«Âõ §º÷ó¾ ÁÕóÐ  
1.«Â¸¡ó¾ ¦ºóàÃõ  
«Ç×: ÌýÈ¢  
«ÛÀ¡Éõ: §¾ý 
¾£Õõ §¿¡ö: ÀÄ §¿¡ö ¾£Õõ           
- ¬¾¡Ãõ: «¸ò¾¢Â÷ ¨Åò¾¢Â ¸¡Å¢Âõ 1500 
 
 
2.¯§Ä¡¸ ¦ºóàÃõ 
«Ç×: 3 À½¦Å¨¼ 
«ÛÀ¡Éõ :§¾ý, À¡ø 
¾£Õõ §¿¡ö:ºÄì¸Æ¢îºø 
                                                     - ¬¾¡Ãõ: «¸ò¾¢Â÷ ¨Åò¾¢Â ¸¡Å¢Âõ 1500 
 
3.º¼¡ðºÃ ÌÁ¡Ã¢ ¦ºóàÃõ  
«Ç×:À½¦Å¨¼ 
«ÛÀ¡Éõ:§¾ý 
¾£Õõ §¿¡ö:Å¡¾õ, Å¡Ô,Ý¨Ä,À¢ò¾õ,ã÷î¨º 
   -¬¾¡Ãõ: «¸ò¾¢Â÷ ¨Åò¾¢Â ¸¡Å¢Âõ 1500 
4.¯§Ä¡¸ ÀüÀõ 
«Ç×:2 À½¦Å¨¼  
«ÛÀ¡Éõ:§¾ý 
¾£Õõ §¿¡ö: ºýÉ¢, À¢Ã§Á¸õ, Å¡Ô, ±Ã¢ÌýÁõ 
- ¬¾¡Ãõ:«¸ò¾¢Â÷ ¨Åò¾¢Â ¸¡Å¢Âõ 1500 
 5.ºõÀ¢Ã¾¡Âî ÝÃ½ÀüÀõ 
«Ç×:§ÅñÊÂ «Ç× 
«ÛÀ¡Éõ:¿£÷,§¾ý 
¾£Õõ §¿¡ö:ÌýÁõ,¸¢Ã¡½¢,«ì¸¢É¢ Áó¾õ  
  
      - ¬¾¡Ãõ:«¸ò¾¢Â÷ ¨Åò¾¢Â ¸¡Å¢Âõ 1500 
6.«Â ¦ºóàÃõ 
«Ç×:1-2 ÌýÈ¢ 
«ÛÀ¡Éõ:§¾ý 
¾£Õõ §¿¡ö:Å¡¾ §¿¡ö, À¢ò¾À¡ñÎ, Å£ì¸õ, ¯½§Åü¸¡¨Á 
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7.ÌÕôÀðÎì ¸ÕôÒ 
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«Ç×:º£Ã¸ò¾Ç× 
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9.«ÂÀüÀõ 
«Ç×:§¾¨ÅÂ¡É «Ç× 
«ÛÀ¡Éõ:§¾ý 
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        - ¬¾¡Ãõ:§¸¡„¡Â¢ 
 
10.«Â «ôÀ¢Ã¸î ¦ºóàÃõ 
«Ç×:1-2 ÌýÈ¢ 
«ÛÀ¡Éõ:¬Å¡ÃõÀð¨¼ àû 
¾£Õõ §¿¡ö:ºÂõ, þÕÁø, þ¨ÃôÀ¢ÕÁø,À¢Ã§Á¸õ. 
                                            -  ¬¾¡Ãõ:«Û§À¡¸ ¨Åò¾¢Â ¿Å¿£¾õ 
 
11.«ÂÅ£Ãî ¦ºóàÃõ 
«Ç×:2-4 «Ã¢º¢ 
«ÛÀ¡Éõ:§¾ý,À¨É¦ÅøÄõ, þïº¢îº¡Ú 
¾£Õõ§¿¡ö:ÌýÁ§¿¡ö, Å¡Ô§¿¡ö, ºýÉ¢ 
      - ¬¾¡Ãõ: «Û§À¡¸ ¨Åò¾¢Â ¿Å¿£¾õ 
Å£Ãõ  
Å£ÃÁ¡ÉÐ  
Á£É¡ðº¢ ¨Áó¾ý,  
âÅ¢óÐ §ºÅ¸ý,  
ºÃìÌî Íñ½õ,  
ÀÈí¸¢ô À¡¼¡½õ,  
º¡Ãò¾¢ý ºòÐÕ,  
ÀÈ¢Á¢òÐÕ,  
¦¸¡îº¢ Å£Ãõ ±ýÈ Àø§ÅÚ ¦ÀÂ÷¸Ç¡ø ÅÆí¸ôÀÎõ.  
Ì½À¡¼õ ¾¡Ð º£Å ÅÌôÒ  
«ýÈ¢Ôõ,  
“²È¢Â Å£Ã¦ÁÅ¨Ãì ÜÊ§É¡ý  
¬È¢Â Å¢üÀýÉ¡¾¢ ¦Åû¨Ç ¦ºóàÃó  
Ý¾È¢Â §ºÅ¸ý §º÷ À¢¼Ã¡¸É¡õ  
ÜÈ¢Â Å£Ãí ¦¸¡û¸¢Â ¿¡Á§Á''  
     ºð¼ÓÉ¢ ¿¢¸ñÎ 1200 
 
Å¢üÀý ¬¾¢ ¦Åû¨Ç ¦ºóàÃõ §ºÅ¸ý À¢¼Ã¡¸ý ±É×õ ÅÆí¸ôÀÎ¸¢ÈÐ.  
 
''Å£Ãò¾¢ý §À÷¾¨É§Â Å¢ÇõÀì§¸Ù  
Å¢Çí¸¢Â§¾¡÷ ¾¢È× ¾¢ÈÛÁ¡Ìõ  
Á¡ÃÁ¡¾¢ ¦Åû¨Ç ¦ºóàÃÁ¡Ìõ  
Á¡¸¡É Å¡¾¢¸Ùì ¦¸üÀÁ¡Ìõ  
Å¡ÃÁ¡õ Å¸¡Ãò¾¢ý ¾¨ÄÅÉ¡Ìõ  
ÁýÉ¢Â§¾¡÷ âÅ¢óÐ ×ò¾õ §ºÅ¸É¡õ  
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ÍÂõÀ¡É Å£Ãò¾¢ý §ÀÕÁ¡§Á ''  
 
          - §À¡¸÷ ¿¢¸ñÎ 1200          
À¡¼¡½ Å¨¸¸û «ÚÀòÐ ¿¡ý¸¢ø Å£ÃÓõ ´ýÚ. þÂü¨¸Â¢ø 
¸¢¨¼ì¸ì ÜÊÂ Å¨¸ ´ýÚ, ¨ÅôÒ À¡¼¡½ Å¨¸ ´ýÚ . þ¾¢ø 
þÂü¨¸Â¢ø ¸¢¨¼ì¸ì ÜÊÂ À¡¼¡½õ ¾ü§À¡Ð ¸¢¨¼ôÀ¾¢ø¨Ä. 
¨ÅôÒÀ¡¼¡½§Á Å£Ãõ ±É ÀÂýÀÎò¾ôÀÎ¸¢ÈÐ. þô¦À¡Õû ¦¸¡ÊÂ 
Å¢¼Á¡Ìõ, «ÇÅ¢ø º¢È¢Ð «¾¢¸ôÀÊÛõ ¿ïº¡¸ì ¦¸¡øÖõ.  
- Ì½À¡¼õ ¾¡Ð º£Å ÅÌôÒ  
 
þÐ ¦Åû¨Ç ¿¢ÈÁ¡É¾¡Ôõ, ±ùÅ¢¾ Å¡º¨ÉÔõ þøÄ¡¾¾¡Ôõ, ´Õ 
Å¢¾ ¸¡ÃÓûÇ¾¡Ôõ ,º¢Ú ÀÇ¢íÌ ¸ü¸¨Çô §À¡Ä¡ÅÐ, ¦ÀÃ¢Â ÀÊ¸ì¸ø¨Äô 
§À¡Ä¡ÅÐ þÕìÌõ. ¦¿ÕôÀ¢Ä¢ð¼¡ø þÄÌÅ¢ø ¯ÕÌõ. ¿£Ã¢Öõ, 
º¡Ã¡Âò¾¢Öõ, ®¾Ã¢Öõ ¾¡Ã¡ÇÁ¡ö ¸¨ÃÔõ .þÃºõ ¦¾¡¼÷À¡É ¦À¡Õð¸Ç¢ø 
¿£Ã¢ø ¸¨ÃÔõ ¾ý¨Á ¯¨¼ÂÐ ¬¸§Å þÐ ¦ºÂ¿£÷ ¾¢Ã¡Å¸í¸Ç¢ø 
Óì¸¢ÂÁ¡¸ §º÷ì¸ôÀÎ¸¢ÈÐ. þì¸ðÊÂ¢ý Á£Ð º¢È¢Ð Íñ½¡õ¨Àò 
¾¼Å¢É¡ø º¢ÅóÐ ¸¡½ôÀÎõ. Å£Ãô¦À¡Ê¨Â Íñ½¡õÒ ¿£Õ¼ý ¸Äó¾¡ø 
Áïºû ¿¢È Åñ¼ø «ÊÂ¢ø ÀÊó¾ À¢ý º¢ÅìÌõ. þÐ ´Õ ¨ÅôÒî ºÃìÌ.  
      - þÃºÅ¡¾ º¢ó¾¡Á½¢ 2õ À¡¸õ 
 
ºùÅ£Ãõ  
þÐ§Å Å£Ãõ ±ýÚ ¦º¡øÄôÀÎõ ´÷ ¨ÅôÒî ºÃìÌ. ¸¨¼¸Ç¢ø 
¸¢¨¼ôÀÐ ÀÊ¸ ¿¢Èõ §À¡Ä «øÄÐ º¢È¢Ð Áí¸Ä¡¸×õ þÕìÌõ. þÐ 
¯¼õÀ¢ý À¢½¢¸¨Ç «¸üÚõ. ãò¾¢Ãõ, Å¢Â÷¨Å¨Âô ¦ÀÕìÌõ Ì½õ 
¯¨¼ÂÐ.  
þÐ ¸¢Ãó¾¢, §Á¸õ, ºÕÁ §¿¡ö, ¸¡ì¨¸ÅÄ¢, Å¡¾ §¿¡ö, ¦¾¡ñ¨¼ 
§¿¡ö þ¨Å¸ðÌ ¯ûÙìÌ ¦¸¡Îì¸×õ, ¸ñ §¿¡ö, Òñ þ¨Å¸Ç¢ø 
¦ÅÇ¢ô À¢Ã§Â¡¸Á¡¸×õ ÀÂýÀÎõ. þ¾üÌ Å¡ö À¢ÊìÌõ «øÄÐ §Å¸î 
¦ºöÔõ Ì½ÓûÇ¾¡ø Ó¨ÈôÀÊ ¯ûÙìÌ ¦¸¡Îì¸ §ÅñÎõ. þÐ Å¡¾ 
Ó¨ÈìÌ ÀÂýÀÎõ.  
  - º¡õÀº¢Åõ À¢û¨Ç ¾Á¢ú «¸Ã¡¾¢ 
Å£Ãõ 
Í¨Å   - ¸¡÷ôÒ,¯ôÒ.  
Å£Ã¢Âõ   - ¦ÅôÀõ  
À¢Ã¢×   - ¸¡÷ôÒ.  
Àïºâ¾ «õºõ - «ôÒ. 
 
¦ºö¨¸ 
¯¼ø §¾üÈ¢ 
¸¢ÕÁ¢ ¿¡º¢É¢  
«Ø¸Ä¸üÈ¢ 
ÒñÏñ¼¡ì¸¢ 
''ÜðÊÂ Å£ÃÓõ Í¼÷ ¦ºôÒò ¦¾¡ðÊÔõ,  
À¡ðÊÉ¢ø ¦ÉøÖõ À¾¢Å¡É §¾öÅ¢§¾ '' .  
Å£ÃÁ¡ÉÐ “Å¢óÐî ºÃìÌ” ±Éì ÜÈôÀÎ¸¢ÈÐ.  
ÀñÒ  
''ÌýÁ¦Á¡Î Ìð¼í ¦¸¡ÊÂ ÅÉ¢Äò ¾¢ÃðÎ,  
Ðý Á¡í¸¢ºô ¦ÀÕì¸ï Ý¨Ä §¿¡ö- Åý¨ÁÔÚ, 
¸¡Á¢Âô Òñ½¡¾¢Â §¿¡ö ¸ñ¼¡üºù  
Å£Ã¦ÉÛï º¡Á¢ ¿¡Áò¨¾ ÔîºÃ¢''  
- À¾¡÷ò¾ Ì½º¢ó¾¡Á½¢   
¦À¡Õû  
ºùÅ£Ãò¾¢ý ¿¡Áò¨¾ ¯îºÃ¢ò¾¡§Ä ÌýÁõ, Ì¨È §¿¡ö, 
¾£í¨¸ Å¢¨ÇÅ¢ì¸¢ýÈ Á¸¡ Å¡¾ §Ã¡¸í¸Ç¢ý Üð¼õ, Ð÷Á¡Á¢º ÅÇ÷îº¢, 
Ý¨Ä §¿¡ö¸û, Åý¨Áô ¦À¡Õó¾¢Â ¦Àñ §À¡¸ò¾¢É¡ø Å¢¨Ç¸¢ýÈ 
¦¸¡ÕìÌ, «¨ÃÂ¡ôÒ Ó¾Ä¢Â Òñ¸û ¿£íÌõ.  
þÐ ÀÄÁ¡É â¾Ãº¸¡Ã¢ þ¨¾ ¯ð¦¸¡ñ¼¡ø ¯¼Ä¢ÖûÇ 
¾¡Ðì¸û «Ø¸¢ô §À¡¸¡Áø þÕì¸ ¦ºö¸¢È ÁÕóÐ. þ¨¾ ÁÕóÐ¸§Ç¡Î 
§º÷ò¾¡ø ºÃìÌ¸û ÁÊóÐ Áì¸¢ò ¾õ Ì½í¸û ¦¸ðÎô §À¡¸¡Áø ¸¡ìÌõ 
Ì½ÓûÇ ÁÕóÐ.  
- þÃºÅ¡¾ º¢ó¾¡Á½¢ 
 ''ÍÃÁñ¼ Å¡Ô ºýÉ¢ ¦¾¡¼÷ÅÇ ÌÁÃ¸ñ¼ý,  
ÅÕÉ¢í ¸ñ¼Á¡¨Ä Å¡¾õ Å¢ôÒÕ¾¢ §¸¡¨Æ,  
¯¨Ã ¦ÀÕ §¿¡ö ¸ÃôÀÛõ ÌòÐô ÒÈÅ£îº¢¨Æ,  
ºÕÅ¢Â ¸¢Ãó¾¢ Ìð¼ï ºùÅ£Ãó ¦¾¡¨ÄìÌÁ¡§Á ''  
¦À¡Õû  
ÍÃõ, «ñ¼Å¡Ô, ºýÉ¢, ÌÁÃ¸ñ¼ÅÄ¢, ºÂõ, ¸ñ¼Á¡¨Ä, 
Å¡¾õ, Å¢ôÒÕ¾¢, §¸¡¨Æ,¦ÀÕ §¿¡ö,¸ÃôÀ¡ý, ¸¢Ãó¾¢, Ìð¼õ Ó¾Ä¢Â¨Å 
ºùÅ£Ãò¾¡ø ¾£Õõ.  
-«Á¢÷¾ º¡¸Ãõ  
Íò¾¢ Ó¨È¸û  
1.'' ¿ÂõÀ¼§Å Å£ÃÁÐ Íò¾¢§¸Ù,  
   ¿øÄ þÇ¿£Ã¢ø ¸üâÃõ §À¡ðÎ  
   ÍÂõÀ¡É ºðÊÂ¢§Ä ¸Äì¸¢ ¦¸¡ñÎ  
   ¦¾¡Ä¡Âó¾¢ÃÁ¡ö Å£Ãò¨¾ì ¸ðÊ§Â¾¡ý  
   ÁÂÁ¡¸ «Îô§Àò¾¢ ¦ÂÃ¢òÐì ¦¸¡ñ¼¡ø  
   ÅÖÅ¡É Å£ÃÓó¾¡ý Íò¾¢Â¡î§º ''  
-Â¡§¸¡Ò ¨Åò¾¢Âõ 300.  
 
2. ¸üâÃò¨¾ Ð¨ÇòÐ, «òÐ¨ÇÂ¢ø Å£Ãò¨¾ ¨ÅòÐ ¸üâÃò¾¡ø ãÊ 
¦¸¡Ùò¾¢Â À¢ý¦ÉÎòÐ ´Õ μðÊø ¸ó¾¸ò¨¾ ¦À¡ÊòÐô §À¡ðÎ «ÊÂ¢ø 
¾£Â¢ðÎ, ¯Õ¸¢ ¿¢üÌõ §À¡Ð Å£Ãò¨¾ ¦ÁÐÅ¡¸ ÒÃðÊ ±Îì¸ Íò¾¢Â¡Ìõ. 
 
 -À¾¢¦Éñ º¢ò¾÷ Ã¡ƒ¨Åò¾¢Â §À¡¾¢É¢.  
 
3. ´Õ ÀíÌ Å£Ãò¾¢üÌ 3 ÀíÌ «¾¢¸Á¡¸ Á¢Ç¨¸ ¸ïº¢ ºÄõ Å¢ðÎ ¦ÁØÌ 
À¾Á¡¸ «¨ÃòÐ Å£Ãò¾¢üÌ «í¸¢ âðÊ º£¨ÄÂ¢ø ÓÊóÐ þÇ¿£Ã¢ø 
«Øó¾¡Áø ÐÄ¡ ±ó¾¢ÃÁ¡¸ ¸ðÊ «¨Ã º¡Áõ ±Ã¢ì¸ Íò¾¢Â¡Ìõ.  
-º¢¸¢îº¡ ÃòÉ ¾£Àõ  
4. À¡¸ü¸¡¨Âô À¢ÇóÐ ¿ÎÅ¢ø Å£Ãì¸ðÊ¨Â ¨ÅòÐì ¸Â¢üÈ¡ø ¸ðÊ 
ÐÄ¡Âó¾¢ÃÁ¡¸ ¿£Ã¢ø ÓØ¸¡Åñ½õ þÇ¿£Ã¢ø «øÄÐ ÀÆîº¡üÈ¢ø ´Õ Á½¢ 
§¿Ãõ ±Ã¢òÐ ±Îì¸ §ÅñÎõ. «ô¦À¡ØÐ Íò¾¢Â¡Ìõ.  
 
-Ì½À¡¼õ ¾¡Ð º£Å ÅÌôÒ  
 
5. Å£Ãò¨¾ ´Õ À£í¸¡É¢Ä¢ðÎ ãúÌõ Å¨Ã ¾¡öôÀ¡ø Å¢ðÎ À¡ø ÓØÅÐõ 
ÍñÎõ Å¨Ã ¦ÅöÂ¢Ä¢ø ¯Ä÷ò¾¢ ±ÎòÐì¦¸¡ûÇ Íò¾¢Â¡Ìõ  
         
 - ºÃìÌ Íò¾¢ ¦ºöÓ¨È¸û 
 
 
6. ÀÊ¸¡Ãõ Ý¼ý Å¨¸ìÌ ´Õ ÀÄõ ±ÎòÐ þÃñ¨¼Ôõ ¦À¡ÊòÐ ¨ÅòÐì 
¦¸¡ñÎ Å£Ãì¸ðÊìÌ ¦¸¡ïºõ ¦¸¡ïºÁ¡ö ¸¢Ã¡ºõ ¦¸¡ÎòÐ ±Îì¸ 
Íò¾¢Â¡Ìõ.¸¢Ã¡ºõ ¦¸¡ÎìÌõ§À¡Ð Å£Ãõ Ò¨¸Â¡Åñ½õ À¡÷òÐì ¦¸¡ûÇ 
§ÅñÎõ  
 
- Ì½À¡¼õ ¾¡Ð º£Å ÅÌôÒ. 
 
7. þÇ¿£Ã¢ø º¢È¢Ð Ý¼¨Éì ¸ÄóÐ ´Õ À¡¨ÉÂ¢Ä¢ðÎ Å£Ãò¨¾ 
ÐÄ¡Âó¾¢ÃÁ¡¸ ¿£Ã¢ø À¼¡Áø «¨Ã Á½¢ §¿Ãõ ±Ã¢òÐ ±Îò¾ø. 
 
-Ì½À¡¼õ ¾¡Ð º£Å ÅÌôÒ. 
8.±Õì¸õÀ¡Ä¢ø Å£Ãò¨¾ ãýÚ ¿¡ð¸û °È ¨Åì¸ Íò¾¢Â¡Ìõ. 
 
   -ºÃìÌ Íò¾¢ ¦ºöÓ¨È¸û 
9. ºùÅ£Ãï Íñ½¡õ§À¡Î º¡üÚÁ¡ Á½ì¸ ¦¿öÂ¢ø  
¦ÅùÅÁ¢ø Íò¾¢Â¡Ìõ  
       - «Á¢÷¾ º¡¸Ãõ  
 
10. ´Õ ÀÄõ Å£Ãò¾¢üÌ Á¢ÇÌì ÌÊ¿£÷ Å¢ðÎ 6 Á½¢ §¿Ãõ ÍÕìÌ 
¦¸¡ÎòÐô À¢ÈÌ Á¢ÇÌì ¸ø¸ò¾¢üÌû ¨ÅòÐ, ´Õ À¡ñ¼ò¾¢ø «¨ÃôÀÊ 
¸È¢ÔôÒ¼ý ´Õ ÀÄõ Ý¼¨Éì ¸ÄóÐ «¾üÌû §ÁüÀÊ Å£Ãò¨¾ô Ò¨¾òÐî 
º¢Ä Á½¢ §¿Ãõ º¢Ú ¾£Â¡ø ±Ã¢òÐ ±ÎôÀÐ.  
  -Ì½À¡¼õ ¾¡Ð º£Å ÅÌôÒ 
11.Å£Ãì¸ðÊ¨Â ¾¡öôÀ¡ø «øÄÐ ÀÍõÀ¡ø Å¢ðÎ ¦ÅöÂ¢Ä¢ø ¸¡Â ¨ÅòÐ 
±ÎòÐì ¦¸¡ûÇ Íò¾¢Â¡Ìõ.  
   -ºÃìÌ Íò¾¢ ¦ºöÓ¨È¸û 
 
12.Å£Ãõ ´Õ ÀÄõ, º£É¡ì¸¡Ãõ ãýÚ ÀÄõ, þÕõÒ ºðÊÂ¢ø º£É¡ì¸¡Ãò¨¾ 
¯Õì¸¢ ¾ñ½£Ã¡É×¼ý Å£Ãì¸ðÊ¨Â þðÎ ¸ò¾¢Â¡ø ÒÃðÊì ¦¸¡ñÎ 
ÅÃ×õ.¸ðÊÂ¡ÉÐ ¸£§Æ «Øó¾¢ Å¢¼¡Áø ¾¼¨ÅìÌ ¾¼¨Å ¦¸¡ïºõ àì¸¢ 
¦¸¡ÎòÐ ÅÃ §ÅñÎõ. þôÀÊ ¦ºöÐ º£É¦ÁøÄ¡õ ÅÈñ¼ À¢ý¦ÉÎòÐ 
¨ÅòÐ ¬È¢É À¢ý ¸ðÊÂ¢ý Á£ÐûÇ º£Éò¨¾ ¸ò¾¢Â¢É¡ø ¦ÁÐÅ¡¸ ÍÃñÊ 
´ýÈ¨Ã ÀÄõ Ý¼¨É àû ¦ºöÐ ¸ðÊÂ¢ý ¸£ú §ÁÄ¢ð¼Øò¾¢ ¦¸¡Ùò¾¢ 
Å¢ð¼¡È¢É À¢ý¦ÉÎò¾¢ì ¦¸¡ûÅ§¾ Íò¾¢Â¡Ìõ.  
    - «Û§À¡¸ ¨Åò¾¢Â ¿Å¿£¾õ À¡¸õ- 4  
 
13. ´Õ ÀÄõ Å£Ãò¨¾ ´Õ þÇ¿£Ã¢ø, ´ý§È¸¡ø ÅÃ¡¸¦É¨¼ ¸üâÃõ 
§À¡ðÎ ¸Äì¸¢ ºðÊÂ¢ø °üÈ¢ «ÎôÀ¢§ÄüÈ¢ §ÁüÀÊ Å£Ãò¨¾ ÐÄ¡Âó¾¢ÃÁ¡¸ 
¸ðÊ ±Ã¢òÐ ±ÎòÐì ¦¸¡ûÇ §ÅñÎõ.  
      -§¸¡‡¡Â¢ «Û§À¡¸ ¨Åò¾¢Â À¢ÃõÁ Ã¸º¢Âõ À¡¸õ-1.  
 Å£Ãõ §ºÕõ ÁÕóÐ¸û.  
1. Å£Ãì¸ÕôÒ  
«Ç×    : 1/4 Ó¾ø 1/2 ÌýÈ¢  
«ÛÀ¡Éõ   : ¦¿ö, ¦Åñ¦½ö, §¾ý  
¾£Õõ§¿¡ö¸û : ÌýÁõ, Ì¨È§¿¡ö.  
 
2. §Ä¡¸Á¡Ã½î ¦ºóàÃõ  
«Ç×    : 1 Ó¾ø 2 ÌýÈ¢  
«ÛÀ¡Éõ       : §¾ý, ¦¿ö, ¦Åñ¦½ö  
¾£Õõ§¿¡ö¸û      : Å¡¾ô À¡ñÎ, §º¡¨¸, ÌýÁõ.  
 
3.þÄ¢í¸ Å£Ãî ¦ºóàÃõ  
«Ç×    :1/2 Ó¾ø 1 ÌýÈ¢  
«ÛÀ¡Éõ       :À¨É¦ÅøÄõ, ¦¿ö, þïº¢ þÇ¸õ  
¾£Õõ§¿¡ö¸û  :ºýÉ¢, Ý¨Ä, Ý¾¸ÅÄ¢, Ý¾¸ºýÉ¢.  
 
4.Å£Ãî¦ºóàÃõ  
«Ç×    :1/4 Ó¾ø 1/2 ÌýÈ¢  
«ÛÀ¡Éõ   :þïº¢ º¡Ú, §¾ý, À¨É¦ÅøÄõ,.  
¾£Õõ §¿¡ö¸û  :Àì¸Å¡¾õ, Å¢¼¡ì¸Æ¢îºø  
 
5.Å£Ã¦ÁØÌ  
«Ç×        :1 Ó¾ø 2 «Ã¢º¢ ±¨¼  
«ÛÀ¡Éõ   : À¨É¦ÅøÄõ 
¾£Õõ§¿¡ö¸û  :ÌýÁõ, Ý¨Ä, Àì¸Å¡¾õ.  
6.Å£Ã ÀüÀõ  
«Ç×    : 1/2 Ó¾ø 1 ÌýÈ¢  
«ÛÀ¡Éõ   : §¾ý, À¨É¦ÅøÄõ  
¾£Õõ§¿¡ö¸û  :ºýÉ¢, ÅÄ¢ôÒ, ÌýÁõ.  
7.Å£ÃôÀ¾í¸õ  
«Ç×    : 1/2 Ó¾ø 1 «Ã¢º¢  
«ÛÀ¡Éõ   : À¨É¦ÅøÄõ, ¦Åñ¦½ö  
¾£Õõ§¿¡ö¸û  : ÌýÁõ, Ìð¼õ, Ý¨Ä, Àì¸Å¡¾õ  
8.Å£ÃÁ¡ò¾¢¨Ã  
«Ç×    : 1/2 Ó¾ø 1  
«ÛÀ¡Éõ   : À¨É¦ÅøÄõ, ¿¡ðÎîº÷ì¸¨Ã  
¾£Õõ§¿¡ö¸û  : 13 Å¨¸ ºýÉ¢, Å¡¾õ.  
9.Å£Ã Ãºî ¦ºóàÃõ  
«Ç×    :1 Ó¾ø 1 1/2 ÌýÈ¢  
«ÛÀ¡Éõ   :§¾ý,Å¢øÅ¡¾¢þÇ¸õ,ÀÈí¸¢ôÀð¨¼ þÇ¸õ.  
¾£Õõ§¿¡ö¸û  :§Á¸Ã½í¸û, Ý¨Ä, «Æ¢ôÒñ,  
 ÌÆ¢ôÒñ, ¸¢Ãó¾¢.  
10.ÍÅ÷½ þÃºî¦ºóàÃõ  
«Ç×    : 1 Ó¾ø 1 1/2 ÌýÈ¢  
«ÛÀ¡Éõ   : ¦ÅøÄõ, §¾ý  
¾£Õõ§¿¡ö¸û  : §Á¸Å¡Ô,Ý¨Ä, Ìð¼õ  
11. Àïº â¾ ¦ºóàÃõ  
«Ç×    : 1/2 Ó¾ø 1 ÌýÈ¢  
«ÛÀ¡Éõ   : À¨É¦ÅøÄõ  
¾£Õõ§¿¡ö¸û   : ÌýÁõ, ¦ÀÕÅÂ¢Ú, Ý¨Ä, ºýÉ¢ 
12. ÀïºÓ¸ ¦ºóàÃõ  
«Ç×    : 1 Ó¾ø 2 «Ã¢º¢ ±¨¼  
«ÛÀ¡Éõ    : À¨É¦ÅøÄõ  
¾£Õõ§¿¡ö¸û  : ±ñÅ¨¸ ÌýÁõ, §Á¸Ý¨Ä, §Á¸Å¡Ô.  
13.Á¸¡Å£Ã¢Âî ¦ºóàÃõ  
«Ç×    : 1 Ó¾ø 2 «Ã¢º¢ ±¨¼  
«ÛÀ¡Éõ   : §¾ý  
¾£Õõ§¿¡ö¸û  : ±ó¾ Å¨¸Â¢Öõ ¬È¡¾ Ã½í¸û  
 
14. Àïºôâ¾ô À¾í¸õ  
«Ç×    : 1 Ó¾ø 2 «Ã¢º¢ ±¨¼  
«ÛÀ¡Éõ   : À¨É¦ÅøÄõ, ¦Åñ¦½ö  
¾£Õõ§¿¡ö¸û   :«ñ¼ Å¡Ô, §Á¸Å¡Ô, ÌýÁõ  
15.§¸¡§Ã¡º¨É ¦ÁØÌ  
«Ç×     : 1/2 Ó¾ø 1 ÌýÈ¢  
«ÛÀ¡Éõ    : À¨É¦ÅøÄõ, ¦Åñ¦½ö  
¾£Õõ§¿¡ö¸û   : Àì¸Å¡¾õ, ¿Ã¢ò¾¨Ä Å¡¾õ  
16.ºñÓ¸ ¦ÁØÌ  
«Ç×     : 1 Ó¾ø 1 1/2 ÌýÈ¢  
«ÛÀ¡Éõ      : À¨É¦ÅøÄõ, º÷ì¸¨Ã  
¾£Õõ§¿¡ö¸û  : Ý¨Ä, «íÌÄ¢ Å¡¾õ  
17.þÃº¦ÁØÌ  
«Ç×     :1/2 Ó¾ø 1 ÌýÈ¢  
«ÛÀ¡Éõ    : À¨É¦ÅøÄõ  
¾£Õõ§¿¡ö¸û   :Ý¨Ä, À¡Ã¢ºÅ¡Ô  
18.ÀïºÝ¾ Á¡ò¾¢¨Ã  
«Ç×     :1 Ó¾ø 2  
«ÛÀ¡Éõ   : À¨É¦ÅøÄõ, ¦¿ö, §¾ý  
¾£Õõ§¿¡ö¸û   : Ó¸Å¡¾õ, Àì¸Å¡¾õ, ÌýÁõ  
19.§Á¸ºïº£Å¢ Á¡ò¾¢¨Ã  
«Ç×     : 1/2 Ó¾ø 1  
«ÛÀ¡Éõ    : º÷ì¸¨Ã, ¦Åñ¦½ö  
¾£Õõ§¿¡ö¸û   : À¢Ã§Á¸õ, º£ú§Á¸õ, ¾ó¾¢§Á¸õ  
20.ÌÕºïº£Å¢ ¦ÁØÌ  
«Ç×     :1/2 Ó¾ø 1 ÌýÈ¢  
«ÛÀ¡Éõ    : §¾ý  
¾£Õõ§¿¡ö¸û  : ¸ñ¼Á¡¨Ä, À×ò¾¢Ãõ, º¢¨ÄôÒñ  
 21. ¿Å§Ä¡¸ ¦ÁØÌ  
«Ç×    : 1/4 Ó¾ø 1/2 ÌýÈ¢  
«ÛÀ¡Éõ   : À¨É¦ÅøÄõ  
¾£Õõ§¿¡ö¸û  :§Á¸§¿¡ö, ¸¢Ãó¾¢ôÒñ¸û, Ý¨Ä 
 
22.þÄÌÅ¡ÉÁ¡ ¦ÁØÌ  
«Ç×    : 1/2 Ó¾ø 1 ÌýÈ¢  
«ÛÀ¡Éõ       : À¨É¦ÅøÄõ, º÷ì¸¨Ã  
¾£Õõ§¿¡ö¸û      :±ñÅ¨¸ ¸¡ºõ, ±ñÌð¼õ,¸¢Ãó¾¢, ¿£Ã¢Æ¢×. 
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IRON 
Overview  
 The period in human history beginning in about 1200 B.C. is called the Iron 
Age. It was at about this time that humans first learned how to use iron metal 
 Iron is a transition metal. The transition metals are the elements that make up 
Groups 3 through 12 in the periodic table. The transition metals are typical metals in 
that they tend to be bright, shiny, silvery solids. They all tend to conduct heat and 
electricity well. And they usually have high melting points. 
     
 
                        
SYMBOL   Fe 
ATOMICNUMBER : 26 
ATOMICMASS: 55.847 
FAMILY : Group8(VIIIB) Transition metal 
PRONUNCIATION  
EYE-um 
Iron normally does not occur as a free element in the earth. In fact, iron was 
not of much value to humans until they learned how to free iron from its compounds. 
Once they could do that, humans were able to make tools, weapons, household 
implements, and other objects out of iron. This step marked the beginning of the Iron 
Age. 
Iron is most valuable not as a pure metal, but in alloys. An alloy is made by 
melting and mixing two or more metals. The mixture has properties different from 
those of the individual metals. The best known and most widely used alloy of iron is 
steel. Steel contains iron and at least one other element. Today, specialized steels of 
all kinds are available for many different applications. 
Discovery and naming 
 Ancient Egyptians had learned how to use iron before the First Dynasty, 
which began in about 3400 B.C. The Egyptians probably found the iron in 
meteorites. Meteorites are chunks of rock and metal that fall from the sky. 
Some meteorites are very rich in iron. The Egyptians made tools and jewelry 
out of iron. 
 Iron is probably the most widely used and most important metal today. 
 Iron was also known to early Asian civilizations. In Delhi, India, for example, 
a pillar made out of iron built in A.D. 415 still stands. It weighs 6.5 metric 
tons and remains in good condition after nearly 1,600 years. 
 Early Chinese civilizations also knew about iron. Workers learned to produce 
iron as early as 200 B.C. A number of iron objects, including cannons, remain 
from the Han period (202 B.C. to A.D. 221). 
 The Bible also includes many mentions of iron. For example, a long passage 
in the book of Job describes the mining of iron. Other passages tell about the 
processing of iron ore to obtain iron metal. 
 By the time of the Roman civilization, iron had become an essential metal. 
The historian Pliny (A.D. 23-79) described the role of iron in Rome: 
 It is by the aid of iron that we construct houses, cleave rocks, and perform so 
many other useful offices of life. But it is with iron also that wars, murders, 
and robberies are effected, and this, not only hand to hand, but from a distance 
even, by the aid of weapons and winged weapons, now launched from 
engines, now hurled by the human arm, and now furnished with feathery 
wings. 
 Even from the earliest days, humans probably seldom used iron in a pure 
form. It was difficult to make iron that was free of impurities, such 
as carbon (charcoal) and other metals. More important, however, it became 
obvious that iron with impurities was a stronger metal that 
iron without impurities. 
 It was not until 1786, however, that scientists learned what it was in steel that 
made it a more useful metal than iron. Three researchers, Gaspard Monge 
(1746-1818), C. A. Vandermonde, and Claude Louis Berthollet (1748-1822) 
solved the puzzle. They found that a small amount of carbon mixed with iron 
produced a strong alloy. That alloy was steel. Today, the vast amount of iron 
used in so many applications is used in the form of steel, not pure iron. 
 Ancient Egyptians had learned how to use iron before the First Dynasty, 
which began in about 3400 B.C. 
 The chemical symbol for iron is Fe. That symbol comes from the Latin name 
for iron, ferrum. 
Physical properties 
Iron is a silvery-white or grayish metal. It is ductile and malleable. It is one of 
only three naturally occurring magnetic elements.Iron has a very high tensile strength. 
The melting point of pure iron is 1,536°C (2,797°F) and its boiling point is 
about 3,000°C (5,400°F). Its density is 7.87 grams per cubic centimeter. The melting 
point, boiling point, and other physical properties of steel alloys may be quite 
different from those of pure iron. 
Chemical properties 
Iron is a very active metal. It readily combines with oxygen in moist air. The 
product of this reaction, iron oxide (Fe 2 O 3 ), is known as rust. Iron also reacts with 
very hot water and steam to produce hydrogen gas. It also dissolves in most acids and 
reacts with many other elements. 
Occurrence in nature 
Iron is the fourth most abundant element in the Earth's crust. Its abundance is 
estimated to be about 5 percent. Most scientists believe that the Earth's core consists 
largely of iron. Iron is also found in the Sun, asteroids, and stars outside the solar 
system. 
The most common ores of iron are hematite, or ferric oxide (Fe 2 O 3 ); 
limonite, or ferric oxide (Fe 2 O 3 ); magnetite, or iron oxide (Fe 3 O 4 ); and siderite, or 
iron carbonate (Fe2CO 3 ). An increasingly important source of iron is taconite. 
Taconite is a mixture of hematite and silica (sand). It contains about 25 percent iron. 
The largest iron resources in the world are in China, Russia, Brazil, Canada, 
Australia, and India. The largest producers of iron from ore in the world are China, 
Japan, the United States, Russia, Germany, and Brazil. 
Isotopes 
There are four naturally occurring isotopes of iron, iron-54, iron-56, iron-57, 
and iron-58. Isotopes are two or more forms of an element. Isotopes differ from each 
other according to their mass number. The number written to the right of the element's 
name is the mass number. The mass number represents the number of protons plus 
neutrons in the nucleus of an atom of the element. The number of protons determines 
the element, but the number of neutrons in the atom of any one element can vary. 
Each variation is an isotope. 
Six radioactive isotopes of iron are known also. A radioactive isotope is one 
that breaks apart and gives off some form of radiation. Radioactive isotopes are 
produced when very small particles are fired at atoms. These particles stick in the 
atoms and make them radioactive. 
Two radioactive isotopes of iron are used in medical and scientific research. 
They are iron-55 and iron-59. These isotopes are used primarily as tracers in studies 
on blood. A tracer is a radioactive isotope whose presence in a system can easily be 
detected. The isotope is injected into the system. Inside the system, the isotope gives 
off radiation. That radiation can be followed by detectors placed around the system. 
Iron-55 and iron-59 are used to study the way in which red blood cells develop in the 
body. These studies can be used to tell if a person's blood is healthy. 
Extraction 
Iron goes through a number of stages between ore and final steel product. In 
the first stage, iron ore is heated with limestone and coke (pure carbon) in a blast 
furnace. A blast furnace is a very large oven in which the temperature may reach 
1,500°C (2,700°F). In the blast furnace, coke removes oxygen from iron ores. 
 limestone removes impurities in the iron ore. 
Iron produced by this method is about 91 to 92 percent pure. The main 
impurity left is carbon from the coke used in the furnace. This form of iron is known 
as pig iron. Pig iron is generally too brittle (it breaks too easily) to be used in most 
products. 
 Most scientists believe that the Earth's core consists largely of iron. 
 A number of methods have been developed for purifying pig iron. A common 
method used today is called the basic oxygen process. In this process, pig iron is 
melted in a large oven. Then pure oxygen gas is blown through the molten pig iron. 
The oxygen burns off much of the carbon in the pig iron:  
 A small amount of carbon remains in the iron. The iron produced in this 
reaction is known as steel. 
 The term "steel" actually refers to a wide variety of products. The various 
forms of steel all contain iron and carbon. They also contain one or more other 
elements, such as silicon, titanium, vanadium, chromium, manganese, cobalt, 
nickel, zirconium, molybdenum, and tungsten. Two other steel-like products are 
cast iron and wrought iron. Cast iron is an alloy of iron, carbon, and silicon. Wrought 
iron contains iron and any one or more of many other elements. In general, however, 
wrought iron tends to contain very little carbon. 
Uses 
It would be impossible to list all uses of iron and steel products. In 
general, those products can be classified into categories: (1) automotive; (2) 
construction; (3) containers, packaging, and shipping; (4) machinery and industrial 
equipment; (5) rail transportation; (6) oil and gas industries; (7) electrical equipment; 
and (8) appliances and utensils. (For more information on specific kinds of steel 
alloys, see individual elements, such as titanium, vanadium, chromium, manganese, 
molybdenum, and tungsten.) 
Compounds 
Some iron is made into compounds. The amount is very small 
compared to the amount used in steel and other iron alloys. Probably the fastest 
growing use of iron compounds is in water treatment systems. The terms ferric and 
ferrous refer to two different forms in which iron occurs in compounds. Some of the 
important iron compounds are: 
The U.S. Recommended Daily Allowance (USRDA) for iron is 18 milligrams. 
ferric acetate (Fe(C 2 H 3 O 2 ) 3 ): used in the dyeing of cloth 
ferric ammonium oxalate(Fe(NH 4 ) 3 (C 2 O 4 ) 4 ): blueprints 
ferric arsenate (FeAsO 4 ): insecticide 
ferric chloride (FeCl 3 ): water purification and sewage treatment systems; dyeing of 
cloth; coloring agent in paints; additive for animal feed; etching material for 
engraving, photography, and printed circuits 
ferric chromate (Fe 2 (CrO 4 ) 3 ): yellow pigment (coloring) for paints and ceramics 
ferric hydroxide (Fe(OH) 3 ): brown pigment for coloring rubber; water purification 
systems 
ferric phosphate (FePO 4 ): fertilizer; additive for animal and human foods 
ferrous acetate (Fe(C 2 H 3 O 2 ) 2 ): dyeing of fabrics and leather; wood preservative 
ferrous gluconate (Fe(C 6 H 11 O 7 ) 2 ): dietary supplement in "iron pills" 
ferrous oxalate (FeC 2 O 4 ): yellow pigment for paints, plastics, glass, and ceramics; 
photographic developer 
ferrous sulfate (FeSO 4 ): water purification and sewage treatment systems; catalyst in 
production of ammonia; fertilizer; herbicide; additive for animal feed; wood 
preservative; additive to flour to increase iron levels 
Health effects 
 Iron is of critical importance to plants, humans, and animals. It occurs in 
hemoglobin, a molecule that carries oxygen in the blood. Hemoglobin picks up 
oxygen in the lungs, and carries it to the cells. In the cells, oxygen is used to produce 
energy the body needs to survive, grow, and stay healthy. 
 The U.S. Recommended Daily Allowance (USRDA) for iron is 18 milligrams. 
The USRDA is the amount of an element that a person needs to stay healthy. Iron is 
available in a number of foods, including meat, eggs, and raisins. 
 An iron deficiency (lack of iron) can cause serious health problems in humans. 
For instance, hemoglobin molecules may not form in sufficient numbers. Or they may 
lose the ability to carry oxygen. If this occurs, a person develops a condition known as 
anemia. Anemia results in fatigue. Severe anemia can result in a lowered resistance to 
disease and an increase in heart and respiratory (breathing) problems. Some forms of 
anemia can even cause death. 
Mercury(II) chloride 
Mercury(II) chloride or mercuric chloride (archaically, corrosive 
sublimate)is the chemical compound of mercury and chlorine with the formulaHgCl2. 
This white crystalline solid is a laboratory reagent and a molecular compound. Once 
used as a treatment for syphilis, it is no longer used for medicinal purposes because 
of mercury toxicity and the availability of superior treatments. 
Production 
Mercuric chloride is not a salt but a linear triatomic molecule, hence its 
tendency to sublime. In the crystal, each mercury atom is bonded to two close 
chloride ligands with Hg—Cl distance of 2.38 Å; four more chlorides are more distant 
at 3.38 Å.  
Mercuric chloride is obtained by the action of chlorine on mercury 
or mercury(I) chloride, by the addition of hydrochloric acid to a hot, concentrated 
solution of mercury(I) compounds such as the nitrate: 
HgNO3 + 2 HCl → HgCl2 + H2O + NO2, 
Heating a mixture of solid mercury(II) sulfate and sodium chloride also 
affords volatile HgCl2, which sublimes and condenses in the form of small rhombic 
crystals. 
Its solubility increases from 6% at 20 °C (68 °F) to 36% in 100 
°C (212 °F). In the presence of chloride ions, it dissolves to give the tetrahedral 
coordination complex [HgCl4]
2- 
Application 
The main application of mercuric chloride is as a catalyst for the 
conversion of acetylene to vinyl chloride, the precursor to polyvinylchloride: 
C2H2 + HCl → CH2=CHCl 
For this application, the mercuric chloride is supported on carbon in 
concentrations of about 5 weight percent. This technology has been eclipsed by the 
thermal cracking of 1,2-dichloroethane. Other significant applications of mercuric 
chloride include its use as a depolarizer in batteries and as a reagent in organic 
synthesis and analytical chemistry . It is being used in plant tissue culture for surface 
sterilisation of explants such as leaf or stem nodes. 
As a chemical reagent 
Mercuric chloride is occasionally used to form an amalgam with 
metals, such as aluminium. Upon treatment with an aqueous solution of mercuric 
chloride, aluminium strips quickly become covered by a thin layer of the amalgam. 
Normally, aluminium is protected by a thin layer of oxide making it inert. Once 
amalgamated, aluminium can undergo a variety of reactions. For example, it will 
dissolve in water (this can be dangerous, as hydrogen gas and heat are 
generated). Halocarbons react with amalgamated aluminium in the Barbier reaction. 
These alkyl aluminium compounds are nucleophilic and can be used in a similar 
fashion to the Grignard reagent. Amalgamated aluminium is also used as a reducing 
agent in organic synthesis. Zinc is also commonly amalgamated using mercuric 
chloride. 
Mercuric chloride is used to remove dithiane groups attached to a 
carbonyl in an umpolung reaction. This reaction exploits the high affinity of Hg
2+
 for 
anionic sulfur ligands. 
Historic use in photography 
Mercury(II) chloride was used as a photographic intensifier to produce 
positive pictures in the colloid on process of the 1800s. When applied to a negative, 
the mercury(II) chloride whitens and thickens the image, thereby increasing the 
opacity of the shadows and creating the illusion of a positive image.  
Historic use in preservation 
For the preservation of anthropological and biological specimens 
during the late 19th and early 20th centuries, objects were dipped in or were painted 
with a "mercuric solution". Objects in drawers were protected by scattering crystalline 
mercuric chloride over them. It finds minor use in tanning, and wood was preserved 
by kyanizing (soaking in mercuric chloride) Mercuric chloride was one of the three 
chemicals used for railroad tie wood treatment between 1830 and 1856 in Europe and 
the United States. Limited railroad ties were treated in the United States until there 
were concerns over lumber shortages in the 1890s. The process was generally 
abandoned because mercuric chloride was water soluble and not effective for the long 
term, as well as poisonous. Furthermore, alternative treatment processes, such 
as copper sulfate, zinc chloride, and ultimately creosote; were found to be less toxic. 
Limited kyanizing was used for some railroad ties in the 1890s and early 1900s.  
Historic use in medicine 
Mercuric chloride was used to disinfect wounds by Arab physicians in 
the Middle Ages. Syphilis was frequently treated with mercuric chloride before the 
advent of antibiotics. It was inhaled, ingested, injected, and applied topically. 
Poisoning was so common that its symptoms were confused with those of syphilis. 
This usage of "salts of white mercury" is referred to in the Englishfolk-song, "The 
Unfortunate Rake". 
Physical Properties 
Melting point  : 277° C(lit) 
Boiling point  :  302 °C 
Density  :  5.44 
Vapor pressure :  1.3mm Hg(236° C)  
Refractive index : 1.859 
Fp   : 302° C 
Storage temp.  : store at RT 
Solubility   :  H2O : soluble 
Form    :  powder 
Water solubility  :  7.4g/100ml (20° C) 
Merk    :  14,5876 
colour   :  white crystals 
Air & water  reactions; slightly soluble in water. 
Reactivity profile  :  
Mercury chloride is decomposed by sunlight. Incompatible with 
formats sulfites, hypophosphites, phosphates, sulfides, albumin, gelatin, alkalis, 
alkaloid salts, lime water, antimony, arsenic, bromides, borax, carbonates, reduced 
iron, copper, lead and silver salts, infusions of cinchona, oak bark or senna, tannic 
acids and vegetable astringents. 
Health hazard  : 
Mercury chloride is classified as extremely toxic. All forms of mercury 
are poisonous if absorbed. Probable oral lethal dose is 5-50 mg/kg; between 7 drops 
and 1 tea spoonful for a 150 lb. person. Mercury chloride is one of the most toxic salts 
of mercury. Material attacks the gastrointestinal tract and renal systems. 
Fire hazard  : 
Material may explode on heating, with friction, or contact with alkali 
metals, sulfides, acetylene, ammonia, and oxalic acid. Upon decomposition highly 
toxic chloride and mercury fumes are emitted. Avoid formats, sulfites, 
hypophosphites, phosphates, sulfide, albumin, gelatins, alkalis, alkaloid salts, 
ammonia, lime water antimony, arsenic, bromides, borax, carbonates, reduced iron, 
copper, iron, lead, lead, silver salts, infusions of cinchona, columbo, oak bark or 
senna, and tannic acid. Mercury chloride may explode with friction or application of 
heat. Mixtures of mercury chloride and sodium or potassium are shock sensitive and 
will explode on impact. Avoid contact with acids or acid fumes 
Related compounds: 
Other anions  
Mercury (II) Fluoride 
 Mercury(II) Bromide 
 Mercury(II) Iodide 
 
Other cations 
 Zinc chloride 
 Cadmium chloride 
 Mercury(I )chloride
Handling and storage: 
  Keep in a tightly closed container, stored in a cool, dry, ventilated area. 
Protect from physical damage and direct sunlight.  Isolate from incompatible 
substances.  Follow strict hygiene practices.  Containers of this material may be 
hazardous when empty since they retain product residues (dust, solids); observe all 
warnings and precautions listed for the product. 
Stability : 
Mercury is stable under ordinary conditions of use and storage.  Slowly 
decomposes to metallic mercury in the presents of organic matter and sunlight, and 
becomes volatile at 300° C (572° F) 
Hazardous Decomposition Products: 
 Oxides of the contained metal and halogens, possibly also free or ionic 
halogen. 
Incompabilities : 
 Reacts violently with potassium and sodium.  Incompatible with many 
compounds : formats, sulphides, phosphates, albumin, ammonia, gelatin, carbonates, 
hypophosphites, sulfides, alkalis, alkaloid salts, lime water, antimony and arsenic, 
bromids, borax, reduced iron copper, iron, lead, tannic acid and vegetable astringents. 
Conditions to Avoid : 
 Heat, shock, friction, incompatibles. 
Ecological Information 
Environmental Fate : 
 For mercury :  This material has an experimentally determined bio 
concentration factor (BCF) of greater than 100.  This material  is expected to 
significantly bio accumulate. 
Environmental Toxicity : 
 24 Hr LC50 rainbow trout (juvenile) : 0.903 mg/L; 
 48 Hr LC50 fathed minnow : 0.037 mg/L; 
 96Hr LC50 bluegill sunfish (size 0.6 g) : 0.16 mg/L (static) 
 Dangerous to the environment.  Very toxic to aquatic organisms; may cause 
long term adverse effects in the aquatic environment. 
Mercury II chloride Therapeutic Application : 
 In the treatment of syphilis, the bichloride is advised hypodermically, in doses of 
one-twelfth to one-sixth of a grain. 
 It is also used as an intestinal antiseptic in typhoid and other conditions of this 
character, as has been  previously stated. 
 The bichloride of mercury in doses of from one-sixtieth to one-thirtieth of a grain 
every two hours has been used successfully in malignant sore throat and 
diphtheria.  It is considered a potent germicide in those cases in which it can be 
safely used. 
 The addition of a small quantity of a sodium chloride solution to the mercuric 
chloride solution will prevent such a decomposition.  It is most commonly used 
upon the skin, to render it aseptic in preparation for surgical operation. 
 It may be used as a gargle for the throat and mouth, and to wash putrid abscess 
cavities, as well as the vagina and bladder. 
 Bichloride of mercury is most commonly used as a Antiseptic. 
 The antiseptic properties of the bichloride of mercury are generally acknowledged 
and this agent as a germ destroyer is in constant use in surgery. 
 Inhalations of the vapor of mercury are administered in the treatment of 
membranous croup and diphtheria, and if any internal use of the agent be 
considered rational, this method certainly could be so considered. 
 If the inflammation abates and the temperature falls after its use in typhoid fever 
and in diphtheria, it is because of the destruction of the bacillus in each case. This 
statement, however, is open to question in its application to all inflammatory 
conditions. 
Oyster shell (calcium carbonate) 
Calcium carbonate is a chemical compound with the formula CaCO3. 
It is a common substance found in rocks in all parts of the world, and is the main 
component of shells of marine organisms, snails, coal balls, pearls, and eggshells. 
Calcium carbonate is the active ingredient in agricultural lime, and is usually the 
principal cause of hard water. It is commonly used medicinally as a calcium 
supplement or as an antacid, but excessive consumption can be hazardous. 
Chemistry 
Calcium carbonate shares the typical properties of other carbonates. Notably: 
It reacts with strong acids, releasing carbon dioxide: 
CaCO3(s) + 2 HCl(aq) → CaCl2(aq) + CO2(g) + H2O(l 
It releases carbon dioxide on heating, called a thermal decomposition reaction, (to 
above 840 °C in the case of CaCO3), to form calcium oxide, commonly 
called quicklime, with reaction enthalpy 178 kJ / mole: 
CaCO3(s) → CaO(s) + CO2(g) 
Calcium carbonate will react with water that is saturated with carbon dioxide 
to form the soluble calcium bicarbonate. 
CaCO3 + CO2 + H2O → Ca(HCO3)2 
This reaction is important in the erosion of carbonate rocks, forming caverns, 
and leads to hard water in many regions. An unusual form for calcium carbonate 
is ikait with crystal water, CaCO3 - 6 H2O. Ikait is only stable below 6°C. 
Oyster shell calcium carbonate 
The material derived from oyster shells is considered to be derived from 
organic source. Oyster shell calcium carbonate is in its purest form with 99.7% assay 
as CaCo3.  
Specifications: 
Analysis report of sanskar: oyster shell : Calcium Carbonate 
Colour  : creamish  
Bulk density : 0.6 to 0.8gms 
Description : Fine, White To Off White Micro Crystalline Powder 
Solubility : Practically Insoluble In Water And In Ethanol (95%), Slightly    
                                    Soluble In Water Containing Carbon Dioxide Or Any   
                                   Ammonium salt. It is soluble with Effervescence in dilute acids. 
Substances insoluble in Acid : 0.5 % 
Arsenic : nil 
Heavy metals : Traces 
Barium : passes test 
Iron : 0.03 
Magnesium and alkali : 1% 
Chloride : 0.02% 
Sulphate : 0.017% 
Loss on drying (1gm aat 200°C) : 2%w/w 
Tapped density: 0.8gms/cc 
Particle size : 100% passes thoroughly sieve of 200 (linear inch) 
Assay : 99.2% as CaCo3 (on dried basis) 
 
Health and dietary applications 
Calcium carbonate is widely used medicinally as an inexpensive 
dietary calcium supplement or gastric antacid. It may be used as a phosphate 
binder for the treatment of hyperphosphatemia (primarily in patients with chronic 
renal failure). It is also used in the pharmaceutical industry as an inert 
filler for tablets and other pharmaceuticals.  
Calcium carbonate is known among IBS sufferers to help reduce diarrhea
. 
Some individuals report being symptom-free since starting supplementation. The 
process in which calcium carbonate reduces diarrhea is by binding water in the bowel, 
which creates a stool that is firmer and better formed. Calcium carbonate supplements 
are often combined with magnesium in various proportions. This should be taken into 
account as magnesium is known to cause diarrhea. 
Calcium carbonate is used in the production of toothpaste and has seen 
resurgence as a food preservative and color retainer, when used in or with products 
such as organic apples or food.  
Excess calcium from supplements, fortified food and high-calcium diets, can 
cause the milk-alkali syndrome, which has serious toxicity and can be fatal. In 1915, 
Bertram Sippy introduced the "Sippy regimen" of hourly ingestion of milk and cream, 
and the gradual addition of eggs and cooked cereal, for 10 days, combined with 
alkaline powders, which provided symptomatic relief for peptic ulcer disease. Over 
the next several decades, the Sippy regimen resulted in renal failure, alkalosis, and 
hypercalcemia, mostly in men with peptic ulcer disease. These adverse effects were 
reversed when the regimen stopped, but it was fatal in some patients with protracted 
vomiting. Milk alkali syndrome declined in men after effective treatments for peptic 
ulcer disease arose. During the past 15 years, it has been reported in women taking 
calcium supplements above the recommended range of 1.2 to 1.5 g daily, for 
prevention and treatment of osteoporosis, and is exacerbated by dehydration. Calcium 
has been added to over-the-counter products, which contributes to inadvertent 
excessive intake. Excessive calcium intake can lead to hypercalcemia, complications 
of which include vomiting, abdominal pain and altered mental status.  
As a food additive it is designated E170; INS number 170. Used as an acidity 
regulator, anticaking agent, stabiliser or colour it is approved for usage in the 
EU, USA and Australia and New Zealand. It is used in some soy milk and almond 
milk products as a source of dietary calcium; one study suggests that calcium 
carbonate might be as bioavailable as the calcium in cow's milk. Calcium carbonate is 
also used as a firming agent in many canned or bottled vegetable products. 
  
 
 
 
 
 
    TOXICOLOGICAL ASPECTS 
IRON POISONING  
Iron poisoning is an iron overload caused by a large excess 
of iron intake and usually refers to an acute overload rather than a gradual one. The 
term has been primarily associated with young children who consumed large 
quantities of iron supplement pills, which resemble sweets and are widely used, 
including by pregnant women—see over nutrition (approximately 3 grams is lethal for 
a 2 year old).  Targeted packaging restrictions in the US for supplement containers 
with over 250 mg elemental iron have existed since 1978, and recommendations for 
unit packaging have reduced the several iron poisoning fatalities per year to almost nil 
since 1998. No known cases of iron poisoning have been identified that are associated 
with iron mining. 
Nature of iron 
In nature, iron is usually found in its oxidized form, iron (III) oxide, 
which is insoluble. Ferrous iron is soluble and its toxicity varies, largely with the 
integrity of the gastrointestinal lining. 
  Iron supplements are typically used to treat anemia. Modalities 
include: diet, parasite control, vitamin A, riboflavin (B2), vitamin C (for absorption), 
folate, vitamin B12 and multivitamin-multi mineral supplements, with or without iron; 
potentially avoiding the use of iron only supplements. 
Toxic dosage 
  The amount of iron ingested may give a clue to potential toxicity. The 
therapeutic dose for iron deficiency anemia is 3–6 mg/kg/day. Toxic effects begin to 
occur at doses above 10–20 mg/kg of elemental iron. Ingestions of more than 
50 mg/kg of elemental iron are associated with severe toxicity.  
A 325-mg tablet of ferrous sulfate has 65 mg (20%) of elemental iron 
A 325-mg tablet of ferrous gluconate has 39 mg (12%) of elemental iron 
A 325-mg tablet of ferrous fumarate has 107.25 mg (33%) of elemental iron 
 In terms of blood values, iron levels above 350-500 µg/dL are considered 
toxic, and levels over 1000 µg/dL indicate severe iron poisoning.  
Symptoms 
  The first indication of iron poisoning by ingestion is a pain in the 
stomach, as the stomach lining becomes ulcerated. This is accompanied by nausea and 
vomiting. The pain then abates for 24 hours as the iron passes deeper into the body 
resulting in metabolic acidosis, which in turn damages internal organs, particularly 
the brain and the liver. The body goes into shock and death from liver failure 
If intake of iron is during a prolonged period of time, symptoms are likely similar to 
other causes of iron overload. 
Treatment 
  Later stage treatment consists of cleaning the iron from the blood, 
using a chelating agent such as deferoxamine. If this fails then dialysis is the next 
step. 
VEERAM(MERCURY II CHLORIDE) POISONOUS EFFECTS: 
Å£Ã ¿ïÍì ÌÈ¢Ì½õ 
þÃò¾¾¢ø Å¢¨ÃÅ¢ø ¸ÄóÐ Å¢¼ò¨¾ Å¢¨ÃÅ¢ø Å¢¨ÇÅ¢ìÌõ. þ¾É¡ø, ¸Ç¢õÒî 
Í¨ÅÔõ , Å¡ö ¿£ÕÈø, Å¡ó¾¢,§À¾¢,þÃò¾ §À¾¢,±îº¢ø Å¢Øí¸¦Å¡ð¼¡ÁüÀÊ 
¦¾¡ñ¨¼ §¿¡¾ø,Ó¸õ Å£í¸ø,§¾¡ø ¦ÅÊòÐî º¢¨Ä ¿£÷ÅÊ¾ø ,Å¡ö, 
¦¾¡ñ¨¼, ¬Á¡ºÂõ, Å£í¸¢ôÒñ½¡¾ø Àì¸ÅÄ¢, ¾¡¸õ, Å¢ì¸ø, ÁÂì¸õ, 
ã÷î¨º,ÅÄ¢,Ó¾Ä¢ÂÉ×õ ¯ñ¼¡õ.«ýÈ¢Ôõ ÁÃ½Ó¼¡õ. 
ÓÈ¢×: 
Ó¨ÈÂ¡¸î ºùÅ£Ã ¦Á¡öÌÆÄ¡ö ¦¸¡ñ¼¡ø 
º¢Ú¦¿Õïº¢ü º¡Úñ½ò ¾£Õõ-«¨ÈÂ§¸û 
¿£Ä§Å Ã¡Ì§Á ¦¿öîºðÊî º¡È¡§Á 
À¡Ä¢ ¦¾ýÉí ¸ûÙõ À¸÷ 
 
 º¢Ú ¦¿Õïº¢üº¡Ú,¿£Ä¢§Å÷ôÀð¨¼ì ¸ø¸õ, ¦¿öîºðÊì ¸£¨Ãîº¡Ú, 
¦¾ýÉí¸û  þ¨Å¸Ç¢¦Ä¡ý¨È ¿ïº¢ýÅý¨ÁìÌ ¾ì¸ «ÇÅ¢ø ¿ïÍ 
ÓÃ¢ÔÁðÎõ ¦¸¡Îì¸ §ÅñÎõ. 
 §¸¡Æ¢Óð¨¼ ¦Åñ¸Õ¨Åò ¾ñ½£÷ «øÄÐ À¡Ö¼ý ¸ÄóÐ «Êì¸Ê 
¦¸¡ÎòÐ Åó¾¡Öõ , þÇ¿£÷,«Õó¾¢É¡Öõ ¿£íÌõ. 
«ñ¼ò¾¢ý ¦Åñ¸Õ¨Å Â¡Å¢ýÀ¡ Ä¢ü¸Äó 
ÐñÎÅÃ Å£Ã ÛÃÁ¸Öí-¸ñ¼Ã¢Å¡ö 
²½ü¦¸¡Ê§Â Â¢Ç¿£ ÃÕó¾¢ÎÛ 
Á¡½ô¦ÀÕ¨Á ÅØòÐ. 
±ýÈ ¸ÕçÃ¡÷ ¾ñ¼¸î ¦ºöÔÇ¡ø ¯½ÃÄ¡õ. 
Inhalation:  
Causes irritation to the respiratory tract. Symptoms include sore throat,Coughing, 
pain, tightness in chest, breathing difficulties, shortness of breath and headache. 
Pneumonitis may develop. Can be absorbed through inhalation with symptoms to 
parallel ingestion. Vapor inhalation can burn the mucous membrane of the nose and 
throat. 
Ingestion:  
 Highly toxic average lethal dose for inorganic mercury salts is about one 
gram. May cause burning of mouth and pharynx, abdominal pain, vomiting, corrosive 
ulceration, bloody diahrroea. May be followed by a rapid and weak pulse , shallow 
breathing, paleness, exhaustion, central nervous problems, tremours and collapse. 
Delayed death may occur. 
Skin Contact:  
 Causes irritaton and burns to skin. Symptoms include redness and pain. May 
cause skin allergy and sensitization. Can be absorbed through the skin with symptoms 
to parallel ingestion. 
Eye Contact:  
 Causes irritation and burns to eyes. Symptoms include redness, pain, blurred 
vision, may cause serious and permanent eye damage. 
Aggravation of Pre-existing Conditions:  
 Persons with nervous disorders, or impaired kidney or respiratory function, or 
a history of allergies or a known sensitization to mercury may be more susceptible to 
the effects of the substance. 
Toxicological Data : 
  Oral rat LD 50:1 mg/kg. 
  Investigated  as a tumorigen, mutgen, reproductive effector. 
Reproductive Toxicity : 
  All forms of mercury can cross the placenta to the fetus, but most of 
what is known has been learned from experimental animals.  See chronic Health 
Hazards. 
Carcinogenicity : 
  EPA / IRIS classification :  Group C – Possible human carcinogen. 
 
  
 
 
 
 
 
 
 
MATERIALS 
      AND  
 METHODS 
MATERIALS AND METHODS: 
TEST DRUG : AYAVEERA CHENDHURAM [AVC] 
Ingredients:  
            Purified ayam (ferrum)                     –  1 palam(35 gm), 
            Purified Veeram(Hydrargyrum per chloride)     _ 1palam 
          Sunnambu theli neer( limestone water)     _  sufficient quantity 
Purification: 
Ayam 
The purification of iron ore (Ayam) is carried out by soak it in fruit juice of syzygium 
cumini and kept in the sunlight to get dried. This process is repeated for six times. 
- Gunapadam thathu jeeva   Vagupu, pg: 91  
Veeram 
 Take Veeram and Piper nigrum seeds in the ratio of 1:3.Ground the seeds with rice 
pottridge until paste form. Gently cover the veeram with that paste and tie with a 
white cloth. Sufficient quantity of tender coconut water is add in to a mud pot. By the 
method of thulaiyandram, prepared veeram was tied witout dipping into the tender 
coconut water and heat for 11/2 hours (1/2 samam). 
                                                                                 Sikicha rathina deepam, pg. no 37 
Sunnambu thelineer 
                    Mix the oyster shell with water in the ratio of 1:4, leave it for 4 hours 
until sedimentation. Finally gently take the upper zone of water without vigorous 
mixing. 
  
Unpurified ayam       purified ayam 
    
 
Unpurified veeram       purified veeram 
           
 
Oyster shell powder        Ayaveera chendhuram 
                   
Preparation of the medicine: 
Method of Preparation: 
 Purified Ayam and Purified Veeram is taken which  should placed in the 
kalvam and ground it with adding sufficient quantity of sunnambu theli neer until 4 
samam, made it in to a single pellet and dried under the sunlight. Then Pellet was 
placed in the mud plate and closed it with similar mud plate. The margins are covered 
with 5 layers of clay cloth, dried and kept in the pit under earth.  Pudam is made with 
cow dung cakes(the weight of the cow dung measures 25 times weight of the prepared 
mud pot). Next morning on being cooled mud plate is removed and processed aya 
veera chendhurum is collected in a container. It must be identified by observing 
colour which will resemble like the flower of the Butea frontosa. 
Dose of drug          :    Two – four kundri(Abrus seed) (120 -520mg) 
Adjuvant                :    Honey, palmjaggery                          
Therapeutic uses   :    Eight types of Gunmam,mega vayu, mega pidipu, pakkavatham, 
oduvayu, pakkasoolai,mega soolai. 
Precautions      :     Ichha pathiyam 
    Anupoga vaithya navaneetham 1 part, pg. no 113 
 
 
 
 
 
 
 
QUALITATIVE ANALYSIS - PHYSICO-CHEMICAL PROPERTIES  
COLOUR  
  About 50 gm of AVC was taken in a clean glass beaker and tested 
for its colour by viewing against a white opaque back ground under direct 
sunlight. 
  
ODOUR         
  About 50 gm of the AVC was placed in 100 ml of  beaker and 
tested for its odour by wafting the air above the beaker. 
 
  pH      
  The pH of the AVC was estimated as per the method prescribed in 
the Indian standard (IS) - 6940(1982). One gram of the AVC was taken into a 
100ml graduated cylinder containing about 50 ml of water and filled up to the 
mark with water. The cylinder was stopped and shaken vigorously for two 
minutes and the suspension was allowed to settle for an hour at 25 to 27˚C. 
About 25 ml of the clear aqueous solution was transferred into a 50 ml beaker 
and tested for pH  using DIGISUN digital pH meter (DIGISUN electronics, 
Hyderabad, India) 
 
DETERMINATION OF ASH VALUE  
  Two gms of the AVC was weighed accurately in tarred  platinum or 
silica dish and incinerated at a temperature not exceeding 450˚C until free from 
carbon, then cooled and weighed. Calculate the percentage of ash with reference of 
the air dried drug. 
 
WATER SOLUBLE ASH 
 To the Gooch crucible containing the total ash, 25 ml of water was added 
and boiled for 5 minutes. The insoluble matter was collected in a sintered glass 
crucible or on ash less filter paper. Washed with hot water and ignited in a 
crucible for 15 minutes at a temperature not exceeding 450˚c. Subtract the 
weight of the insoluble matter from the weight of the ash. The difference of 
the weight represents the water soluble ash. Calculate the percentage of water 
soluble ash with reference to the air dried drug. 
ACID INSOLUBLE ASH 
                Ash was boiled for 5 minutes with 25 ml of 1:1 diluted. Hcl. 
The insoluble matter was collected in a Gooch crucible and placed on an ash 
less filter paper, washed with water and then ignited. Finally cooled in a 
desiccators and weighed. The percentage of insoluble ash was calculated with 
reference to the air dried drug. 
LOSS ON DRYING 
Five grams of the AVC was heated in a hot air at 105˚c to a 
constant weight.    The percentage loss of weight was calculated as per procedure. 
BIO -CHEMICAL ANALYSIS
 
OF AYAVEERA  CHENDHURAM –  
ANALYSED AT NATIONAL INSTITUTE OF SIDDHA 
                Appearance of sample Dark brown in colour 
S.
no 
EXPERIMENT OBSERVATION INFERENCE 
1. Solubility: 
a. A little (500mg) of the sample is 
shaken well with distilled water. 
b. A little (500mg) of the sample is 
shaken well with con. HCl/Con. 
H2So4 
 
 
 
 
Sparingly soluble 
 
 
 
 
Presence of Silicate 
2. Action of Heat: 
   A small amount (500mg) of the 
sample is taken in a dry test tube 
and heated gently at first and then 
strong. 
 
 
 
No White fumes 
evolved 
 
 
 
Absence of 
Carbonate 
3. Flame Test: 
  A small amount (500mg) of the 
sample is made into a paste with 
con. HCl in a watch glass and 
introduced into non-luminous part 
of the Bunsen flame. 
 
 
 
No Bluish green 
flame appeared 
 
 
 
Absence of copper 
4. Ash Test: A filter paper is soaked 
into a mixture of sample and dil. 
cobalt nitrate solution and 
introduced into the Bunsen flame 
and ignited 
Yellow colour 
flame appeared 
 
presence of Sodium 
 
Preparation of Extract: 
5gm of Ayaveera chenduram is weighed accurately and placed in a 250ml 
clean beaker and added with 50ml of distilled water. Then it is boiled well for about 
10 minutes. Then it is cooled and filtered in a 100ml volumetric flask and made up to 
100ml with distilled water. 
 
 
 I.Test For Acid Radicals 
 
S.
no 
EXPERIMENT OBSERVATION INFERENCE 
1 Test For Sulphate :  
2ml of the above prepared extract is 
taken in a test tube to this added 2ml 
of 4%dil. ammonium oxalate 
solution. 
 
 
No cloudy 
appearance  
appeared 
 
 
Absence of 
sulphate 
2 Test For Chloride: 
2ml of the above prepared extracts is 
added with 2ml of dil-HCl is added 
until the effervescence ceases off. 
 
 
No cloudy 
appearance  
appeared 
 
 
Absence of 
chloride 
3 Test For Phosphate: 
2ml of the extract is treated with 2ml 
of ammonium molybdate solution 
and 2ml of con.HNO3 
 
 
Mild yellow 
appearance present 
 
 
Presence of 
Phosphate 
4 Test For Carbonate:  
2ml of the extract is treated with 
2mldil. magnesium sulphate solution 
 
No Cloudy 
appearance seen  
 
Absence  of 
Carbonate 
5 Test For Fluoride & Oxalate: 
2ml of extract is added with 2ml of 
dil. Acetic acid and 2ml dil.calcium 
chloride solution and heated. 
 
 
 
 
 
 
 6 Test For Nitrate: 
1gm of the substance is heated with 
copper turning and concentrated 
H2SO4 and viewed the test tube 
vertically down 
 
 
No brown gas 
evolved 
 
 
Absence of nitarte 
7 Test For Sulphide:  
1gm of the substance is treated with 
2ml of con. HCL 
 
No Rotten Egg 
Smelling gas  
evolved 
 
Absence of 
sulphide 
8 Test For Nitrite: 
  3drops of the extract is placed on a 
filter paper, on that-2 drops of 
dil.acetic acid and 2 drops of dil. 
Benzidine solution is placed. 
 
 
No characteristic 
changes  
 
 
Absence of Nitrite 
9 Test For Borate: 
  2 Pinches (50mg) of the substance 
is made into paste by using 
dil.sulphuric acid and alcohol (95%) 
and introduced into the blue flame. 
 
 
Bluish green colour 
flame not appeared 
 
 
Absence Of Borate 
 
II. Test For Basic Radicals 
 
1 Test For Lead: 
        2ml of the extract is added with 
2ml of dil.potassium iodine solution. 
 
 
No Yellow 
Precipitate is 
obtained. 
 
 
Absence of lead 
2 Test For Copper: 
 One pinch (50mg) of substance is 
made into paste with con. HClin a 
watch glass and introduced into the 
non-luminuous part of the flame. 
 
 
 
No blue  colour    
 
Precipitate formed. 
 
 
 
Absence of Copper 
 3 Test For Aluminium: 
  To the 2ml of extract dil.sodium 
hydroxide is added in 5 drops to 
excess. 
 
 
No Yellow colour 
appeared 
 
 
 
Absence of 
Aluminium 
4 Test For Iron: 
a. To the 2ml of extract add 
2ml of thiocyanate ammonium 
solution 
b. To the 2ml of extract add 
2ml of  thiocyanate ammonium 
solution and 2ml  of con HNO3 . 
 
 
  
 
Red colour 
appeared  
 
 
 
 
 Presence of iron  
5 Test For Zinc:  
      To 2ml of the extract dil.sodium 
hydroxide solution is added in 5 
drops to excess and dil.ammonium 
chloride is added.  
 
 
White precipitate is 
not formed  
 
 
Absence of Zinc 
6 Test For Calcium:  
      2ml of the extract is added with 
2ml of 4% dil.ammonium oxalate 
solution  
 
Cloudy appearance 
and white 
precipitate is 
obtained 
 
 
Presence of 
Calcium  
7 Test For Magnesium:  
To 2ml of extract dil.sodium 
hydroxide solution is added in drops 
to excess. 
 
 
White precipitate is 
obtained 
 
 
Presence Of 
Magnesium 
8 Test For Ammonium: 
  To 2ml of extract 1 ml of Nessler's 
reagent and excess of dil.sodium 
hydroxide solution are added. 
 
 
No Brown colour 
appeared 
 
 
Absence of 
Ammonium 
 9 Test For Potassium:  
   A pinch (25mg) of substance is 
treated off with 2ml of dil.sodium 
nitrite solution and then treated with 
2ml of dil.cobalt nitrate in 30% 
dil.glacial acetic acid. 
 
 
 
No yellowish 
precipitate is 
obtained 
 
 
 
Absence of  
Pottasium 
10 Test For Sodium: 
   2 pinches (50mg) of the substance 
is made into paste by using HCl and 
introduced into the blue flame of 
Bunsen burner. 
 
Yellow colour 
flame appeared 
Presence of sodium 
11 Test For Mercury:  
   2ml of the extract is treated with 
2ml of dil.sodium hydroxide 
solution.  
 
Yellow precipitate 
is obtained 
 
Presence of 
Mercury 
12 Test For Arsenic:  
   2ml of the extract is treated with 
2ml of dil.sodium hydroxide 
solution. 
 
No Brownish red 
obtained  
 
Absence of Arsenic 
 
                                           III.Miscellaneous 
 
1  Test For Starch:  
 2ml of extract is treated with weak 
dil.iodine solution  
 
 
No blue colour 
devolopped 
 
 
Absence of  Starch 
2 Test For Reducing Sugar:5ml of 
Benedict's qualitative solution is 
taken in a test tube and allowed to 
boil for 2 minutes and added 8 to 10 
drops of the extract and again boil it 
for 2 minutes. The colour changes 
are noted 
 
 
 
Brick red colour 
not devolopped  
 
 
 
Absence of 
reducing sugar 
3 Test For The Alkaloids: 
a) 2ml of the extract is treated with 
2ml of dil.potassium lodide solution. 
b)  2ml of the extract is treated with 
2ml of dil.picric acid. 
c)  2ml of the extract is treated with 
2ml of dil.phosphotungstic acid. 
 
 
 
Yellow colour not 
developed 
 
 
 
Absence of 
alkaloid 
4 Test For Tannic Acid:  
  2ml of extract is treated with 2ml 
of dil.ferric chloride solution 
 
 
black precipitate 
obtained 
 
 
presence of Tannic 
acid 
5 Test For Unsaturated Compound: 
  To the 2ml of extract 2ml of 
diluted Potassium permanganate 
solution is added.  
 
 
Potassium 
permanganate 
solution is 
decolourised 
 
 
Presence of 
Unsaturated 
compounds 
6 Test For Amino Acid: 
    2 drops of the extract is placed on 
a filter paper and dried well. 20ml of 
Biurette reagent is added. 
 
 
Violet  colour  not 
developed 
 
 
Absence of  
 
Aminoacid 
7 Test For Type Of Compound: 
    2ml of the extract is treated with 2 
ml of dil.ferric chloride solution.  
 
 
No  Brown  colour 
developed 
 
 
Absence  of  Oay  
quinole, Pinephrine  
and  Pyro catechol 
 
1.INDUCTIVELY COUPLED PLASMA OPTICAL EMISSION 
SPECTROMETRY (ICP-OES)  
 
Introduction  
The elemental composition of a sample is often an important part of the 
information needed to assess its properties. Hence there is a need for sensitive 
scientific instrumentation like ICP-OES which plays a pivotal role in the 
determination of these elements. ICP-OES is widely employed for the estimation of 
metals and metalloids at trace, minor and major concentrations.  
 
Principle  
In this technique, the high temperature plasma source atomizes the sample and 
excites the atoms resulting in emission of photons .The atoms of each element in the 
sample emit specific wavelength of light. The emission spectrum from the plasma is 
dispersed by an optical spectrometer, so that intensities of the individual wavelength 
can 64 be measured. The number of photons emitted is directly proportional to the 
concentration of the element. The photon may be detected either sequentially or 
simultaneously. Quantitative analysis is achieved by measuring the intensity of these 
specific wavelengths and after performing the calibration using known standards.  
Extraction of information  
Obtaining qualitative information, i.e., what elements are present in the 
sample, involves identifying the presence of emission at the wavelengths 
characteristic of the elements of interest. Obtaining quantitative information, i.e., how 
much of an element is in the sample, can be accomplished using plots of emission 
intensity versus concentration called calibration curves. Typical calibration graph is 
illustrated below 
                   
 
 
  
Experimental Procedure: Done at SAIF, IIT Madras, Chennai-36  
  Sample preparation – Microwave Digestion Weigh 0.25g of test 
sample and transfer into a liner provided with the instrument.  Slowly add 9ml of 
Nitric acid or Sulphuric acid such that no piece of sample sticks on the slides. Mix 
thoroughly and allow reacting for few minutes.  Place the liner in the vessel jacket.  
Close the screw cap hand-tight in clockwise direction. Seal the vessel and place in the 
rotor fixed in microwave. Set temperature to 180°C for 5 minutes; hold at 180°C for 
least 10 minutes.  Allow the vessels to cool down to a vessel interior temperature 
below 60°C and to a vessel surface temperature (IR) below 50°C before removing the 
rotor. The digested sample was made upto 100ml with millipore water.  If visible 
insoluble particles exist, solution could be filtered through whatmann filter   paper.  
Transfer the digested solution into plastic containers and label them properly.  
 
2.SCANNED ELECTRON MICROSCOPY (SEM)  
  A SEM is essentially a high magnification microscope, which uses a 
focussed scanned electron beam to produce images of the sample, both top-down and, 
with the necessary sample preparation, cross-sections. The primary electron beam 
interacts with the sample in a number of key ways:-  
 Primary electrons generate low energy secondary electrons, which tend to 
emphasize the topographic nature of the specimen.  
 Primary electrons can be backscattered which produces images with a high 
degree of atomic number (Z) contrast.  
 Ionized atoms can relax by electron shell-to-shell transitions, which lead to 
either X-ray emission or Auger electron ejection. The X-rays emitted are 
characteristic of the elements in the top few μm of the sample.  
 
The SEM is carried out by using FEI-Quanta FEG 200-High Resolution Instrument. 
Resolution: 1.2 nm gold particle separation on a carbon substrate  
Magnification: From a min of 12x to greater than 1, 00,000 X  
Application: To evaluate grain size, particle size distributions, material homogeneity 
and inter metallic distributions. 
  
Experimental Procedure: Done at SAIF, IIT Madras, Chennai-36  
Sample preparation: Sample preparation can be minimal or elaborate for SEM 
analysis, depending on the nature of the samples and the data required. Minimal 
preparation includes acquisition of a sample that will fit into the SEM chamber and 
some accommodation to prevent charge build-up on electrically insulating samples. 
Most electrically insulating samples are coated with a thin layer of conducting 
material, commonly carbon, gold, or some other metal or alloy. The choice of 
material for conductive coatings depends on the data to be acquired: carbon is most 
desirable if elemental analysis is a priority, while metal coatings are most effective for 
high resolution electron imaging applications. Alternatively, an electrically insulating 
sample can be examined without a conductive coating in an instrument capable of 
"low vacuum" operation. 
 
 
3. FOURIER TRANSFORM - INFRA RED SPECTROSCOPY  
PERKIN ELMER – SPECTRUM ONE  
Introduction  
Vibrational spectroscopy is an extremely useful tool in the elucidations of 
molecular structure. The spectral bands can be assigned to different vibrational modes 
of the molecule. The various functional groups present in the molecule can be 
assigned by a comparison of the spectra with characteristic functional group 
frequencies. As the positions of the bands are directly related to the strength of the 
chemical bond, a large number of investigations including intermolecular interactions, 
phase transitions and chemical kinetics can be carried out using this branch of 
spectroscopy.  
In IR spectroscopy, the resonance absorption is made possible by the change 
in dipole moment accompanying the vibrational transition. The Infrared spectrum 
originates from the vibrational motion of the molecule. The vibrational frequencies 
are a kind of fingerprint of the compounds. This property is used for characterization 
of 60 organic, inorganic and biological compounds. The band intensities are 
proportional to the concentration of the compound and hence qualitative estimations 
are possible. The IR spectroscopy is carried out by using Fourier transform technique.  
Principle  
Infra red spectroscopy involves study of the interaction of electromagnetic 
radiation with matter. Due to this interaction, electromagnetic radiation characteristic 
of the interacting system may be absorbed (or emitted). The experimental data consist 
of the nature (frequency of wave length) and the amount (intensity) of the 
characteristic radiation absorbed or emitted. These data are correlated with the 
molecular and electronic structure of the substance and with intra- and inter molecular 
interactions.  
FT-IR spectroscopy is used primarily for qualitative and quantitative analysis 
of organic compounds, and also for determining the chemical structure of inorganic 
materials. The region between 500-4000 wave numbers is referred to as the finger 
print region. Absorption bands in this region are generally due to intra molecular 
phenomena and are highly specific for each material. The specificity if these bands 
allow computerized data searches to be performed against reference libraries to 
identify a material. 
 
Table of Characteristic IR Absorptions 
Frequency, cm–1 Bond Functional group 
3640–3610 (s, sh) 
 
O–H stretch, free hydroxyl alcohols, phenols 
3500–3200 (s,b) 
 
O–H stretch, H–
bonded 
alcohols, phenols 
3400–3250 (m) 
 
N–H stretch primary, secondary amines, 
amides 
3300–2500 (m) 
 
O–H stretch carboxylic acids 
3330–3270 (n, s) 
 
–C(triple bond)C–H: 
C–H stretch 
alkynes (terminal) 
3100–3000 (s) 
 
C–H stretch Aromatics 
3100–3000 (m) =C–H stretch Alkenes 
3000–2850 (m) 
 
C–H stretch Alkanes 
2830–2695 (m) 
 
H–C=O: C–H stretch Aldehydes 
2260–2210 (v) C(triple bond)N stretch Nitriles 
2260–2100 (w) 
 
–C(triple bond)C– 
stretch 
Alkynes 
1760–1665 (s 
 
C=O stretch carbonyls (general) 
1760–1690 (s) 
 
C=O stretch carboxylic acids 
1750–1735 (s) 
 
C=O stretch esters, saturated aliphatic 
1740–1720 (s) 
 
C=O stretch aldehydes, saturated aliphatic 
1730–1715 (s) 
 
C=O stretch alpha,beta–unsaturated esters 
1715 (s) C=O stretch ketones, saturated aliphatic 
1710–1665 (s) 
 
C=O stretch alpha,beta–unsaturated aldehydes, 
ketones 
1680–1640 (m) 
 
–C=C– stretch Alkenes 
1650–1580 (m) 
 
N–H bend primary amines 
1600–1585 (m) 
 
C–C stretch (in–ring) Aromatics 
1550–1475 (s) 
 
N–O asymmetric 
stretch 
nitro compounds 
1500–1400 (m) 
 
C–C stretch (in–ring) Aromatics 
1470–1450 (m) 
 
C–H bend Alkanes 
1370–1350 (m) 
 
C–H rock Alkanes 
1360–1290 (m) 
 
N–O symmetric stretch nitro compounds 
1335–1250 (s) C–N stretch aromatic amines 
1320–1000 (s) C–O stretch alcohols, carboxylic acids, esters, 
ethers 
1300–1150 (m) 
 
C–H wag (–CH2X) alkyl halides 
1250–1020 (m) 
 
C–N stretch aliphatic amines 
1000–650 (s) 
 
=C–H bend Alkenes 
950–910 (m) 
 
O–H bend carboxylic acids 
910–665 (s, b) N–H wag primary, secondary amines 
900–675 (s) C–H "oop" Aromatics 
850–550 (m) 
 
C–Cl stretch alkyl halides 
725–720 (m) 
 
C–H rock Alkanes 
700–610 (b, s) 
 
–C(triple bond)C–H: 
C–H bend 
Alkynes 
690–515 (m) 
 
C–Br stretch alkyl halides 
m=medium, w=weak, s=strong, n=narrow, b=broad, sh=sharp 
Sampling techniques: 
There are a variety of techniques for sample preparation depending on the physical 
form of the sample to be analyzed. 
Solid     : KBr or Nujol mull method. 
Liquid  : CsI / TlBr Cells 
Gas    :       Gas cells  
Experimental Procedure: Done at SAIF, IIT Madras, Chennai-36 
KBr Method 
 The sample was grounded using- an agate mortar and pestle to give a very 
fine powder.  
 The finely powder sample was mixed with about 100mg dried KBr salt.  
 The mixture was then pressed under hydraulic press using a die to yield a 
transparent disc ( measure about 13mm diameter and 0.3mm in thickness), 
through which the beam of spectrometer passed. 
4. X-Ray Fluorescence (XRF) 
An X-ray fluorescence (XRF) spectrometer is an x-ray instrument used for 
routine, relatively non-destructive chemical analyses of rocks, minerals, sediments 
and fluids. It works on wavelength-dispersive spectroscopic principles that are similar 
to an electron microprobe (EPMA). However, an XRF cannot generally make 
analyses at the small spot sizes typical of EPMA work (2-5 microns), so it is typically 
used for bulk analyses of larger fractions of geological materials. The relative ease 
and low cost of sample preparation, and the stability and ease of use of x-ray 
spectrometers make this one of the most widely used methods for analysis of major 
and trace elements in rocks, minerals, and sediment. 
Fundamental Principles of X-Ray Fluorescence (XRF) 
The XRF method depends on fundamental principles that are common to 
several other instrumental methods involving interactions between electron beams and 
x-rays with samples, including: X-ray spectroscopy (e.g., SEM - EDS), X-ray 
diffraction (XRD), and wavelength dispersive spectroscopy. Analysis of major and 
trace elements in geological materials by x-ray fluorescence is made possible by the 
behavior of atoms when they interact with radiation. When materials are excited with 
high-energy, short wavelength radiation (e.g., X-rays), they can become ionized. If 
the energy of the radiation is sufficient to dislodge a tightly-held inner electron, the 
atom becomes unstable and an outer electron replaces the missing inner electron. 
When this happens, energy is released due to the decreased binding energy of the 
inner electron orbital compared with an outer one. The emitted radiation is of lower 
energy than the primary incident X-rays and is termed fluorescent radiation. Because 
the energy of the emitted photon is characteristic of a transition between specific 
electron orbitals in a particular element, the resulting fluorescent X-rays can be used 
to detect the abundances of elements that are present in the sample. 
Procedure 
The analysis of major and trace elements in geological materials by XRF is 
made possible by the behavior of atoms when they interact with X-radiation. An XRF 
spectrometer works because if a sample is illuminated by an intense X-ray beam, 
known as the incident beam, some of the energy is scattered, but some is also 
absorbed within the sample in a manner that depends on its chemistry. The incident 
X-ray beam is typically produced from a Rh target, although W, Mo, Cr and others 
can also be used, depending on the application.  
 
When this primary X-ray beam illuminates the sample, it is said to be excited. 
The excited sample in turn emits X-rays along a spectrum of wavelengths 
characteristic of the types of atoms present in the sample. How does this happen? The 
atoms in the sample absorb X-ray energy by ionizing, ejecting electrons from the 
lower (usually K and L) energy levels. The ejected electrons are replaced by electrons 
from an outer, higher energy orbital. When this happens, energy is released due to the 
decreased binding energy of the inner electron orbital compared with an outer one. 
This energy release is in the form of emission of characteristic X-rays indicating the 
type of atom present. If a sample has many elements present, as is typical for most 
minerals and rocks, the use of a Wavelength Dispersive Spectrometer much like that 
in an EPMA allows the separation of a complex emitted X-ray spectrum into 
characteristic wavelengths for each element present. Various types of detectors (gas 
flow proportional and scintillation) are used to measure the intensity of the emitted 
beam. The flow counter is commonly utilized for measuring long wavelength (>0.15 
nm) X-rays that are typical of K spectra from elements lighter than Zn. The 
scintillation detector is commonly used to analyze shorter wavelengths in the X-ray 
spectrum (K spectra of element from Nb to I; L spectra of Th and U). X-rays of 
intermediate wavelength (K spectra produced from Zn to Zr and L spectra from Ba 
and the rare earth elements) are generally measured by using both detectors in 
tandem. The intensity of the energy measured by these detectors is proportional to the 
abundance of the element in the sample. The exact value of this proportionality for 
each element is derived by comparison to mineral or rock standards whose 
composition is known from prior analyses by other techniques. 
X-Ray fluorescence is particularly well-suited for investigations that involve 
 bulk chemical analyses of major elements (Si, Ti, Al, Fe, Mn, Mg, Ca, Na, K, 
P) in rock and sediment 
 bulk chemical analyses of trace elements (in abundances >1 ppm; Ba, Ce, Co, 
Cr, Cu, Ga, La, Nb, Ni, Rb, Sc, Sr, Rh, U, V, Y, Zr, Zn) in rock and sediment - 
detection limits for trace elements are typically on the order of a few parts per 
million 
 X-ray fluorescence is limited to analysis of 
 relatively large samples, typically > 1 gram 
 materials that can be prepared in powder form and effectively homogenized 
 materials for which compositionally similar, well-characterized standards are 
available 
 materials containing high abundances of elements for which absorption and 
fluorescence effects are reasonably well understood 
In most cases for rocks, ores, sediments and minerals, the sample is ground to a fine 
powder. At this point it may be analyzed directly, especially in the case of trace 
element analyses. However, the very wide range in abundances of different elements, 
especially iron, and the wide range of sizes of grains in a powdered sample, makes the 
proportionality comparison to the standards particularly troublesome. For this reason, 
it is common practice to mix the powdered sample with a chemical flux and use a 
furnace or gas burner to melt the powdered sample. Melting creates a homogenous 
glass that can be analyzed and the abundances of the (now somewhat diluted) 
elements calculated. 
Strengths 
X-Ray fluorescence is particularly well-suited for investigations that involve: 
 bulk chemical analyses of major elements (Si, Ti, Al, Fe, Mn, Mg, Ca, Na, 
K, P) in rock and sediment 
 bulk chemical analyses of trace elements (>1 ppm; Ba, Ce, Co, Cr, Cu, Ga, 
La, Nb, Ni, Rb, Sc, Sr, Rh, U, V, Y, Zr, Zn) in rock and sediment 
Experimental Procedure: Done at Sastra university, Tanjore. 
TOXICOLOGICAL EVALUATION OF AYAVEERA CHENDHURAM 
SCOPE OF WORK 
Preclinical drug development is a stage that begins before clinical trials during which 
important safety and pharmacology data are collected. Regulatory toxicity studies are 
conducted in animals to identify possible hazards from which an assessment of risk to 
humans is made by extrapolation. The choice of animal species is based on the 
similarities of its metabolism to humans 
The goals of the non clinical safety evaluation includes 
 Categorization of toxic effects with respect to target organs, dose 
dependence, relationship to exposure and potential reversibility. This 
information is important for the estimation of an initial safe starting dose 
for the human trial  
 The identification of specific parameters for clinical monitoring for 
potential adverse effect 
Systemic toxicity studies  
Single dose study 
 Single dose studies (acute toxicity) in animals are essential for any 
pharmaceutical products intended for human use .the information obtained from these 
studies is useful in choosing doses for repeated dose studies, providing preliminary 
identification of target organs of toxicity and occasionally revealing delayed toxicity. 
Acute toxicity studies may also aid in the selection of starting doses for phase I 
human studies and provide information relevant to acute over dosing in humans 
Repeated dose systemic toxicity studies 
 The primary goal of repeated dose toxicity studies is to characterize the 
toxicological profile of the cell compound following repeated administration. This 
includes identification of potential target organs of toxicity and exposure /response 
relationship and may include the potential reversibility of toxic effects. This 
information should be part of the safety assessment to support the conduct of human 
clinical trials and the approval of marketing authorization. 
PLAN OF WORK 
 The following studies carried out in AVC are 
 Acute oral toxicity study – OECD 423 guideline 
 28 days Repeated oral toxicity study – OECD 407 guideline 
TEST DRUG – AYAVEERA CHENDHURAM 
The toxicity studies were evaluated after getting permission from the Institutional 
Animal Ethical Committee certificate. (1248/ac/09/CPCSEA/4-34/ 2011).  
ACUTE TOXICITY STUDY OF AYAVEERA CHENDHURAM 
PRINCIPLE OF THE TEST  
It is the principle of the test that, based on a stepwise procedure with the use of 
a minimum number of animals per step, sufficient information is obtained on the 
acute toxicity of the test substance to enable its classification. The substance is 
administered orally to a group of experimental animals at one of the defined doses. 
The substance is tested using a stepwise procedure, each step using three animals of a 
single sex (normally females). Absence or presence of compound-related mortality of 
the animals dosed at one step will determine the next step, i.e.;  
− no further testing is needed,  
− dosing of three additional animals, with the same dose 
 − dosing of three additional animals at the next higher or the next lower dose level 
Experimental animal: 
Species and strain                :   Wister Albino rat 
 Sex                                      :   Male and female 
 Age/Weight            :   6 weeks/150-200 gm 
Test guideline                       :   OECD guidelines - 423 
Groups/treatment                 :   Grouped by randomization 
Duration of exposure to  
“Ayaveera chendhuram”      :   Single dose 
Study duration                      :   14 days              
Number of animals                :   6/group, 3/sex 
Route of administration         :   Oral    
Groups No of Rat 
Group I  control  3 female 
Group II test drug – 5mg/kg b.wt 3 female 
Group III test drug– 50 mg/kg b.wt 3 female 
Group IV test drug – 300 mg/kg b.wt 3 female 
Group V test drug – 2000 mg/kg b.wt  3 female 
                       
   Acute oral toxicity of the formulations were evaluated in rats 
following OECD guideline - 423. Animals were divided into five groups, each group 
containing  3 females; weight: 150 - 200g; age: 6 weeks. One group served as control 
and the others for test drug at four different doses (5mg, 50mg, 300mg, 2000mg 
/kg.b.w) by oral gavage.   
TEST ANIMALS  
                      Test animals were obtained from srinivasa animal laboratory, Bangalore 
and kept at animal house, National Institute of Siddha, Chennai. All the animals were 
kept under standard environmental condition (22 ± 3˚c).The animals had free access 
to water and standard pellet diet (Sai Meera foods pvt. Ltd, Bangalore). The principles 
of laboratory animal care were followed. 
IDENTIFICATION OF ANIMAL: 
By cage number and individual marking on the fur of each animals with picric acid. 
HOUSING & ENVIRONMENT:  
The animals were housed in polypropylene cages provided with bedding of husk. 
ROUTE OF ADMINISTRATION:  
Oral route was selected, because it is the normal route of clinical administration. 
TEST SUBSTANCE AND VEHICLE 
The Ayaveera chendhuram is dark brown coloured, without taste and odour. The test 
substance is insoluble in water. In order to obtain and ensure the uniformity in drug 
distribution; the drug is dissolved by 10% aqueous tween 80 solution.  
ADMINISTRATION OF DOSES 
        Ayaveera chendhuram was suspended in 10% aqueous tween 80 solution with 
uniform mixing and it was administered to the test groups in a single oral dose. The 
control groups were received equal volume of the vehicle. The animals were weighed 
before giving the drug. Test drug at four different doses (5mg, 50mg, 300mg, 2000mg 
/kg.b.w) was administered by oral gavage.   
OBSERVATION: 
a. Behaviour: 
 
  The animals were observed closely for behaviour in the first four hours which  
includes abnormal gait, aggressiveness, exophthalmos , ptosis , akinesia, catalepsy, 
convolusion, excitation, head twitches, lacrimation, loss of corneal reflex, loss of 
traction, piloerection  reactivity of touch, salivation, scratching, sedation, stereotypes 
(chewing),  stereotypes(head movements), stereotypes (sniffing), straub, tremor and 
writhes, diarrhea, leathery, sleep and coma.(Table.8) 
b. Body weight  
 Body weights were recorded at day 1, 2, 7 and 14 of the study. 
c. Mortality :  
 Animals were observed for mortality throughout the entire period. 
d. Gross necropsy: 
  At 14
th
 day animals were sacrificed for gross necropsy. It includes 
examination of the external surface of the body, all orifices, and organs like brain, 
thymus, lungs, heart, spleen, liver, kidneys, adrenals and sex organs of all animals. 
  
 
REPEATED ORAL TOXICITY STUDY OF AYAVEERA CHENDHURAM 
 Species and strain                :     Wister albino rats 
  Sex                                     :      Male and Female 
  Age/Weight            :      6 weeks/150-200mg 
  Test guideline                      :     OECD guidelines – 407 
  Groups/treatment                 :     Grouped by randomization 
  Duration                              :     28 days      
  Number of animals               :     10/group (5/sex) 
  Route of administration        :     Oral    
Groups No of Rats 
Group I  control  6 (3male,3 female) 
Group II test drug - low dose(18.72mg) 6 (3male,3 female) 
Group III test drug - Mid dose(93.65mg) 6 (3male,3 female) 
Group IV test drug - High dose(187.2mg) 6(3male, 3 female) 
 
  The study will be carried out as per OECD Guideline 407 (Repeated Dose 28-
Day Oral Toxicity in Rodents). The animals will be divided in four groups each group 
consist of 6 animals (3 males and 3 females). One group will serve as control and the 
other three groups for test drug at three dose levels (low, mid and high) for 28 days.  
ANIMAL SOURCE:      
      Test animals were obtained from The King Institute, Chennai, and kept at 
animal house, National Institute of Siddha, Chennai. All the animals were kept under 
standard environmental condition (22 ± 3ºc) .The animals had free access to water and 
standard pellet diet (Sai Meera foods pvt. Ltd, Bangalore). The principles of 
laboratory animal care were followed. 
RANDOMIZATION, NUMBERING AND GROUPING OF ANIMAL 
          The animals were randomly divided into four groups. Each group consist 
of 6 animals (3 per sex in each group) first group was kept as control and remaining 
groups as test were treated with test drug in different doses. The animals were allowed 
for an acclimatization period of 7 days to laboratory conditions prior to the initiation 
of treatment. The females were nulliparous and non pregnant. 
IDENTIFICATION OF ANIMAL: 
  Animals were identified by cage number and individual marking on the fur of 
each animal with picric acid. 
HOUSING & ENVIRONMENT:  
The animals were housed in polypropylene cages provided with bedding of husk. 
Dark and light cycle each of 12 hours was maintained. 
ADMINISTRATION PERIOD: 
                       28 days      
DOSE SELECTION: 
 Repeated oral toxicity study was carried out at different dose levels (18.72 mg, 
93.6 mg and 187.2). The selected doses were calculated according to body weight and 
surface area of rat. The human therapeutic dose of AVC is 1040mg/day. 
PREPARATION AND ADMINISTRATION OF DOSE       
  AVC was suspended in 10% aqueous tween 80 solution. It was administered 
to groups I, II, III at dose levels of X therapeutic dose (18.72mg/animal), 5 X 
therapeutic doses (93.6mg/animal) and 10 X therapeutic dose (187.2mg/animal). The 
control animals were administered vehicle only. Administration was given orally 
using an oral gavage once in daily for 28 days. 
Observations: 
BODY WEIGHT:  
                  During the study,    Body weight of the animals was evaluated weekly 
(Table.9) 
FOOD AND WATER INTAKE: 
              Water and  food consumption was evaluated daily (Table.10) 
MORTALITY:  
             Animals were observed for mortality daily. 
 
LABORATORY INVESTIGATIONS: 
Collection of blood: 
             Blood was collected in all overnight (12 hours) fasted rats through cardiac 
puncture method and it will be processed for below mentioned investigations. 
 
Laboratory test: 
Complete haemogram 
Renal function test 
Liver function test 
 
NECROPSY: 
          By the end of 28 days, the animals were sacrificed by excessive anesthesia. 
Animals were subjected to gross necropsy. Vital organs collected from the animals 
were subjected to histopathology.  
 
HISTOPATHOLOGY:                                                                                                                                                                                                                                                                                              
                           Animals were subjected to histopathological investigations. Various 
organs will be collected from all animals and preserved in 10% buffered neutral 
formalin, sliced 5 or 6µm sections and it will be stained with hematoxylin and eosin, 
examined for histopathological changes. 
 
STATISTICAL ANALYSIS: 
 Findings such as clinical sings of intoxication, body weight changes, food 
consumption, hematology, and biochemical parameters were subjected to one-way 
ANOVA followed by Dunnet “t” test using a computer software programme-
INSTAT-V3 version. 
 
  
 
 
 
 
 
 
 
 
    
               RESULTS 
RESULTS 
Table: 1.Physicochemical properties of Ayaveera  Chenduram. 
 
S No. 
 
Parameters  
Values 
obtained 
(%w/w) 
 
Heavy/ toxic metals 
1 Total ash value  8.33 Lead BDL 
2 Acid insoluble ash  0.75 Cadmium BDL 
3 Loss on Drying at 105°C 0.86%   
4 Water soluble ash  6.78 Mercury BDL 
5 Moisture content  10.12 Arsenic BDL 
 
 Table: 2 SIEVE ANALYSIS 
 
 
 
 
 
 
 Table: 3 Colour, nature and percent yields of extracts of  Ayaveera  
Chenduram. 
S.no. Extract 
Solvents 
Colour Nature 
 
% 
Yield(w/w) 
 
SEM-Micro 
graph partical 
size range in 
Nm 
pH 
1 Water Dark 
brown 
Solid        49 50 – 100 nm 8.3 – 
8.5 
 
S.No Sieve No 
(µ) 
% of particles 
retained 
1. 600  Nil 
2. 300  3.2 
3. 150  5.92 
4. 75  54.74 
5. Final 
product 
34.74 
Image :1 HR SEM Analysis - Determination of particle size of Ayaveera  
chenduram           
 
             
 
Particle size of aya veera chenduram is approximately measured as 71.42 nm 
 
Table : 4  
INDUCTIVELY COUPLED PLASMA OPTICAL EMISSION 
SPECTROMETRY OF AVC 
 
S.
no 
 
Elements 
 
Wavelength 
in  nm 
 
Unpurifi
ed ayam 
(fe) 
mg/L 
 
Purified 
ayam 
(fe) 
mg/L 
 
Unpurifi
ed 
veeram 
mg/L 
 
Purifie
d 
veeram 
mg/L 
 
Aya veera 
chendura
m mg/L 
1 Arsenic As193.696 BDL BDL BDL BDL 
BDL 
 
 
2 
Calcium Ca 317.933 20.589 2.452 10.942 6.215 9.268 
 
3 
Cadmium Cd 226.502 BDL BDL BDL BDL BDL 
 
4 
Mercury Hg 253.652 BDL BDL 124.514 95.362 3.145 
 
5 
Iron Fe 238.204 652.441 523.859 8.145 4.651 192.982 
 
6 
Potassium K 766.490 28.985 16.148 12.658 8.745 7.654 
 
7 
Sodium Na 589.592 20.416 9.245 19.642 11.584 8.884 
 
8 
Phosphate P 213.617 36.125 13.362 30.845 22.685 24.196 
 
9 
Lead Pb 230.204 BDL BDL BDL BDL BDL 
 
10 
Magnesium Mg 257.610 15.652 9.245 BDL BDL 4.847 
 
11 
Silicon S 181.975 17.356 8.254 7.519 5.249 7.347 
 
12 
Copper Cu324.754 BDL 
BDL 
 
BDL BDL BDL 
 
 
Table: 5 
 FTIR analysis in the samples of AVC 
Frequency, cm–1 Unpurified 
ayam 
Purified 
ayam 
Unpurifi
ed 
veeram 
Purifie
d 
veeram 
AVC 
3640–3610 (s, sh) - - - - + 
3500–3200 (s,b) - - - - - 
3400–3250 (m) + + + + - 
3300–2500 (m) + - + + + 
3330–3270 (n, s) - + - - + 
3100–3000 (s) - - - - - 
3100–3000 (m) - - - - - 
3000–2850 (m) + + - + - 
2830–2695 (m) - - - - + 
2260–2210 (v) + - + - - 
2260–2100 (w) - - - - - 
1760–1665 (s) - - - - - 
1760–1690 (s) - + - - - 
1750–1735 (s) - - - - - 
1740–1720 (s) - - - - - 
1730–1715 (s) - - - - - 
1715 (s) - - - - - 
1710–1665 (s) - - - - - 
1680–1640 (m) - - - - - 
1650–1580 (m) - - - - + 
1600–1585 (m) - + - - - 
1550–1475 (s) - - - - - 
1500–1400 (m) - + - - - 
1470–1450 (m) - - - - - 
1370–1350 (m) - - - - - 
1360–1290 (m) - - - - - 
1335–1250 (s) - - - - - 
1320–1000 (s) - - + + - 
1300–1150 (m) - - - - - 
1250–1020 (m) - + + + + 
1000–650 (s) + + + + - 
950–910 (m) - - - - - 
910–665 (s, b) - - + + - 
900–675 (s) + + + + - 
850–550 (m) - - + + - 
725–720 (m) - - - - - 
700–610 (b, s) - - - - + 
90–515 (m) - - - - - 
 
 
The schematic graph of FTIR analysis is shown below 
Graph: 1 FTIR analysis of unpurified Ayam(Fe) 
 
                 
 
 
Graph: 2  FTIR analysis of purified Ayam(Fe) 
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Graph: 3 FTIR analysis of unpurified Veeram 
 
 
Graph: 4 FTIR analysis of purified Veeram 
 
 
 
Graph: 5 FTIR analysis of Ayaveera chendhuram 
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Table: 6 XRFAnalysis of Ayaveera chenduram in elemental form 
Formula Z Concenteration Status  line 1 Net.int. cal.conc 
Fe 26 42.05% XRF 0 Fe KA1-HR-Tr 4935 0.0806% 
O 8 37.04% XRF 0 0 KA1-HR 2.566 9.51% 
Si 14 12.51% XRF 0 Si KA1-HR-Tr 217.6 0.384% 
Al 13 3.52% XRF 0 Al KA1-HR-Tr 46.80 0.832% 
Cl 17 1.22% XRF 0 Cl KA1-HR-Tr 32.52 1.00% 
Mn 25 0.83% XRF 0 Mn KA1-HR-Tr 79.94 0.646% 
Ca 20 0.77% XRF 0 Ca KA1-HR-Tr 34.05 0.977% 
Na 11 0.50% XRF 0 Na KA1-HR-Tr 2.674 4.02% 
Ti 22 0.48% XRF 0 Ti KA1-HR-Tr 29.27 1.07% 
Mg 12 0.42% XRF 0 Mg KA1-HR-Tr 6.788 2.61% 
K 19 0.24% XRF 0 K KA1-HR-Tr 9.256 1.92% 
Cr 24 0.15% XRF 0 Cr KA1-HR-Tr 13.91 1.64% 
S 16 0.14% XRF 0 S KA1-HR-Tr 6.078 2.39% 
Hg 80 0.08% XRF 0 Hg LA1-HR-Tr 6.894 2.95% 
Cu 29 0.06% XRF 0 Cu KA1-HR-Tr 5.453 3.13% 
As 33 0.05% XRF 0 As KA1-HR-Tr 9.736 2.37% 
P 15 0.05% XRF 0 P KA1-HR-Tr 1.033 6.47% 
Ba 56 0.04% XRF 0 Ba LA1-HR-Tr 0.8640 9.40% 
Ni 28 0.02% XRF 0 Ni KA1-HR-Tr 1.593 7.64% 
Sr 38 92ppm XRF 0 Sr KA1-HR-Tr 3.882 6.80% 
Zr 40 83ppm XRF 0 Zr KA1-HR-Tr 4.658 6.57% 
Mo 42 77ppm XRF 0 Mo KA1-HR-Tr 3.957 9.44% 
 
Table:7 XRF Analysis of Ayaveera chenduram in oxide form 
Formula Z Concenteration Status  line 1 Net.int. cal.conc 
Fe2o3 26 60.12% XRF 1 Fe KA1-HR-Tr 4935 0.0806% 
Sio2 14 26.77% XRF 1 Si KA1-HR-Tr 217.6 0.384% 
Al2o3 13 6.27% XRF 1 Al KA1-HR-Tr 46.80 0.832% 
Cl 17 1.22% XRF 1 Cl KA1-HR-Tr 32.52 1.00% 
Mno 25 1.08% XRF 1 Mn KA1-HR-Tr 79.94 0.646% 
Cao 20 1.08% XRF 1 Ca KA1-HR-Tr 34.05 0.977% 
Na2o 11 0.68% XRF 1 Na KA1-HR-Tr 2.674 4.02% 
Tio2 22 0.80% XRF 1 Ti KA1-HR-Tr 29.27 1.07% 
Mgo 12 0.70% XRF 1 Mg KA1-HR-Tr 6.788 2.61% 
K2o 19 0.29% XRF 1 K KA1-HR-Tr 9.256 1.92% 
Cr2o3 24 0.22% XRF 1 Cr KA1-HR-Tr 13.91 1.64% 
So3 16 0.35% XRF 1 S KA1-HR-Tr 6.078 2.39% 
Hg 80 0.08% XRF 1 Hg LA1-HR-Tr 6.894 2.95% 
Cuo 29 0.07% XRF 1 Cu KA1-HR-Tr 5.453 3.13% 
As2o3 33 0.06% XRF 1 As KA1-HR-Tr 9.736 2.37% 
P2o5 15 0.11% XRF 1 P KA1-HR-Tr 1.033 6.47% 
Ba0 56 0.04% XRF 1 Ba LA1-HR-Tr 0.8640 9.40% 
Nio 28 0.03% XRF 1 Ni KA1-HR-Tr 1.593 7.64% 
Sro 38 0.01% XRF 1 Sr KA1-HR-Tr 3.882 6.80% 
Zro2 40 0.01% XRF 1 Zr KA1-HR-Tr 4.658 6.57% 
Moo3 42 0.01% XRF 1 Mo KA1-HR-Tr 3.957 9.44% 
 
TOXICITY STUDY 
Acute oral toxicity study 
         All the data´s were summarized in the form of table (8) showing 
the animals behavioral signs in control and test groups. There was no mortality at the 
dose level of 5mg, 50mg, 300mg & 2000mg/Kg b.wt animal. 
Long term toxicity study  
Clinical signs  
            No abnormal behavioral signs were observed during the study period. 
Mortality 
            The test drug AVC did not cause any mortality in X (18.72mg/animal), 5X 
(93.65mg/animal) and 10X (187.2mg/animal) dose levels and were considered as safe 
dose levels. 
Body weight  
          Both control and test dose groups exhibited normal body weight throughout the 
study period. (Table.9) 
Food consumption  
           No difference in food intake of control and test group animals observed during 
the period of study.  
Water intake 
       No difference in water intake of control and test group animals observed 
during the period of study. (Table10) 
Hematological   investigations  
             The results of hematological investigation conducted at the end of the 
study, test groups revealed no significant changes in values of different parameters, 
when compared with control group. The Hemoglobin and TRBC count was slightly 
elevated in test groups, but statistically not significant when compared with control 
group. (Table 11.) 
Biochemical investigations  
            Biochemical investigations were conducted at the end of the study 
and the results were recorded. In test groups there was no significant elevation in 
the levels of biochemical parameters, when compared with the control group. And 
the values obtained were within normal biological limits.(Table 12) 
 HISTOPATHOLOGY: 
 Tissue samples of organs from control and treated animals were preserved in 
10% formalin for preparation of sections using microtome. The organs included liver, 
kidneys, heart, lungs and stomach of the animals were preserved and they were 
subjected to histopathological examination. 
 The organ pieces (3-5 micron ) were fixed in 10% formalin for 24 hours and 
washed in running water for 24 hours .Samples were dehydrated in tissue processor 
and then cleaned in benzene to remove absolute alcohol .Embedding  was done by 
passing the cleared sample through three cups containing molten paraffin at 50 degree 
c and then a cubical block of paraffin made by the L moulds it was followed by 
microtome and the slides were stained with haematoxylin–eosin stain .Stained 
sections of each organ were examined under light microscope at high (40X) power 
magnification.  
Acute oral toxicity 
Table 8: Dose finding experiment and its behavioral Signs of Toxicity 
N
o 
Dose 
mg/
kg 
1 2 3 4 5 6 7 8 9 
1
0 
1
1 
1
2 
1
3 
1
4 
1
5 
1
6 
1
7 
1
8 
1
9 
2
0 
1. 5 + - - + - + - - - - - - - - - - - - - - 
2 50 + - - - + + - - - - - - - - - - - - - - 
3 300 + - - + + + - + - - - - - - - - - - - - 
4 2000 + - - + + + - + - - - - - - - - + - - - 
 
1.Alertness 2. Aggressiveness 3. Pile erection 4. Grooming  5. Gripping  6. Touch Response 7. 
Decreased Motor Activity 8. Tremors 9. Convulsions 10. Muscle Spasm 11. Catatonia 12. Muscle 
relaxant 13. Hypnosis 14. Analgesia 15.Lacrimation 16. Exophthalmos 17. Diarrhoea 18. Writhing 
19. Respiration 20. Mortality (+  Present, -  Absent) 
Table.9. Body wt (g) of Wistar rats in long term toxicity study treated with 
AVC 
 
NS- Not Significant, *(p >0.05), n = 6 values are mean ± S.D (One way ANOVA 
followed by Dunnett’s test) 
Table.10. Water (ml/day) of Wistar rats in long term toxicity study treated with 
AVC 
DOSE 
(mg/animal) 
DAYS 
1 7 14 21 28 
CONTROL 25.55 ± 2.54 23.60 ± 2.83 33.05 ± 3.59 34.5 ± 4.57 30.15 ± 3.24 
X – GROUP 34.33 ± 3.44 31.01 ± 2.66 34.48 ±  4.17 42.6 ± 4.15 37.23 ± 3.44 
5X – GROUP 35.47 ± 3.89 38.23 ± 3.36 31.86 ± 3.89 36.77 ± 3.33 38.19 ± 4.53 
10 X – 
GROUP 
33.49 ± 4.58 40.22 ± 4.25 36.76 ± 3.09 44.47 ± 5.55 41.13 ± 4.12 
P value (p)* NS NS NS NS NS 
N.S- Not Significant, *(p >0.05), n = 6 values are mean ± S.D (One way ANOVA 
followed by Dunnett’s test) 
 
DOSE 
(mg/animal) 
DAYS 
1 7 14 21 28 
CONTROL 141.55 ± 3.57 143.60 ± 3.82 149.05 ± 3.54 
153.50 ± 
4.54 
152.15 ± 3.24 
X – GROUP 142.33 ± 2.36 149.01 ± 2.66 151.48 ± 3.44 
150.60 ± 
4.15 
151.13 ± 3.11 
5X – GROUP 144.47 ± 4.12 149.23 ± 3.44 149.86 ± 4.89 
151.77 ± 
3.23 
152.19 ± 3.53 
10 X -GROUP 149.49 ± 3.89 151.22 ± 4.25 150.76 ± 3.09 
153.47 ± 
5.55 
155.13 ± 4.58 
P value (p)* NS NS NS NS NS 
Table.11. Haematological parameters of Wistar rats in long term toxicity study 
treated   with AVC 
Category Control X Dose 5X Dose 10X Dose P value 
(p)* 
Haemoglobin(g/d
l) 
12.1±0.6 13.4±0.5 13.5±0.7 13.1±0.3 N.S 
Total WBC 
(cells/cu.mm) 
4851±450 5677±320 5899±431 5677±329 N.S 
Platelets/ul 136839.67 126770.17 129097.57 129823.4 N.S 
Total RBC 4.2±0.1 5.1±0.2 5.3±0.1 5.2±0.1 N.S 
ESR(mm) 100 100 100 100 N.S 
PCV 48.101.88 46.122.56 46.443.65 47.202.11 N.S 
MCH pg 18.280.45 17.210.44 18.660.32 18.580.42 N.S 
MCHC g/dl 30.660.98 31.060.42 31.171.30 30.680.55 N.S 
Differential count 
Neutrophils(%) 42±8 35±9 24±8 26±9 N.S 
lymphocyte (%) 55±10 78±8 76±3 77±8 N.S 
Monocyte (%) 2.00.48 2.60.42 2.390.40 2.430.30 N.S 
Eosinohil(%) 1.100.22 1.220.30 2.00.28 1.780.24 N.S 
Basophils(%) 0 0 0 0 N.S 
N.S- Not Significant, *(p >0.05), n = 6 values are mean ± S.D (One way ANOVA 
followed by Dunnett’s test) 
Table.12. Biochemical Parameters of Wistar rats in long term toxicity study 
treated with AVC 
BIOCHEMICAL 
PARAMETERS 
CONTROL 
X 
GROUP 
5X 
GROUP 
10X 
GROUP 
P Value 
(p)* 
GLUCOSE (R) (mg/dl) 100 ± 20 112 ±18 116 ± 12 90 ± 25 N.S 
T.CHOLOSTEROL(mg/dl) 68 ± 7 70 ±10 67 ± 5 71 ± 4 N.S 
HDL(mg/dl) 20 ± 4 23 ± 5 22 ± 5 24 ± 2 N.S 
LDL(mg/dl) 22 ± 7 22 ± 8 20 ± 6 22 ± 6 N.S 
VLDL(mg/dl) 27 ± 4 25 ± 4 25 ± 6 25 ± 4 N.S 
TRIGLY(mg/dl) 133 ± 20 127 ± 17 124 ± 28 129 ±18 N.S 
 
NS- Not Significant,* (p >0.05), n = 6 values are mean ± S.D (One way ANOVA 
followed by Dunnett’s test) 
Table.13. Renal function test of Wistar rats in long term toxicity study treated 
with  AVC   
PARAMETERS CONTROL X - GROUP 
5X - 
GROUP 
10X - 
GROUP 
P Value 
(p)* 
UREA (mg/dl) 28 ± 16 26 ± 3 28±7 30 ± 6 N.S 
CREATININE(mg/d
l) 
0.76 ± 0.25 0.69 ± 0.10 0.66 ± 0.09 0.72 ± 0.12 N.S 
URIC ACID(mg/dl) 2.51 ± 0.20 2.57 ± 0.36 2.38 ± 0.50 2.43 ± 0.37 N.S 
CALCIUM(mg/dl) 8.8 ± 0.8 9.0 ± 0.8 9.5 ± 0.6 10.1 ± 0.6 N.S 
POTASSIUM 
(mg/dl) 
2.7 ± 0.4 2.7 ± 1 3.6 ± 0.5 4.1 ± 0.6 N.S 
 NS- Not Significant,* (p >0.05) , n = 6 values are mean ± S.D (One way ANOVA 
followed by Dunnett’s test) 
Table.14. Liver Function Test of Wistar rats in long term toxicity study treated 
with   AVC 
PARAMETERS CONTROL X - GROUP 
5X - 
GROUP 
10X - 
GROUP 
P Value 
(p)*  
T.BILIRUBIN(mg/dl) 0.9 ± 0.1 0.8 ± 0.1 0.8 ± 0.2 0.9 ± 0.2 N.S 
D.BILIRUBIN(mg/dl) 0.3 ± 0.0 0.3 ± 0.1 0.4 ± 0.1 0.4 ± 0.1 N.S 
I. BILIRUBIN(mg/dl) 0.6 ± 0.1 0.5 ± 0.1 0.4 ± 0.2 0.5 ± 0.1 N.S 
SGOT(U/dl) 67 ± 25 70 ± 23 68 ± 16 63 ± 16 N.S 
SGPT(U/dl) 77 ± 31 80 ± 27 86 ± 23 82 ± 22 N.S 
ALP(U/dl) 132 ± 6 142 ± 25 140 ± 8 146 ± 20 N.S 
T.PROTEIN(mg/dl) 7.0 ± 0.9 6.7 ± 0.3 6.8 ± 0.5 7.1 ± 0.4 N.S 
ALBUMIN(mg/dl) 3.3 ± 0.6 3.4 ± 0.4 3.2 ± 0.3 3.3 ± 0.2 N.S 
GLOBULIN(mg/dl) 3.7 ± 0.3 3.3 ± 0.2 3.6 ± 0.5 3.7 ± 0.3 N.S 
NS- Not Significant,* (p >0.05), n = 6 values are mean ± S.D (One way ANOVA 
followed by Dunnett’s test) 
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         Control group           1x –A  
     
 5x –B           10x - C   
    
                           FIGURE.1 
2.HISTOPATHOLOGY OF KIDNEY 
 
        Control group     1x –A  
        
             5x –B       10x - C 
       
                                      
                                        FIGURE.2 
 3.HISTO PATHOLOGY OF LIVER 
 
          Control group     1x –A 
       
  
             5x –B       10x - C 
        
FIGURE.3 
 
4.HISTO PATHOLOGY OF LUNG 
           Control group     1x –A 
         
             5x –B       10x - C 
       
     FIGURE.4 
 5.HISTO PATHOLOGY OF PANCREAS 
           Control group     1x –A 
         
 
                5x –B              10x - C 
        
                                      FIGURE.5 
6. HISTO PATHOLOGY OF SPLEEN 
           Control group    1x –A 
      
                5x –B              10x - C 
       
                              FIGURE.6 
 
7. HISTOPATHOLOGY OF STOMACH 
 
           Control group    1x –A 
         
             5x –B                             10x - C 
      
                             FIGURE.7 
 9.3g TREATED (low dose) X 
Kidney: shows normal renal tissue with glomeruli and tubules.  
Spleen: shows normal spleen with lymphoid aggregation. 
Liver: shows almost normal hepatocytes and occasional binucleate cells. 
Stomach: shows normal mucosal glands  
Lung: shows normal alveoli. 
Heart: shows normal cardiac muscle bundles. 
Pancreas: shows normal acini with islets of β-cells 
IMPRESSION: NORMAL STUDY 
46.5mg TREATED (Mid dose) 5X 
Kidney: shows renal tissue with focal tubular damage, interstitial inflammatory 
collection. Glomeruli shows epithelial proliferation.  
Liver: shows hepatocytes with focal mild fatty change.  
Spleen: shows congestion with lymphoid hyperplasia.  
Stomach: shows near normal mucosal gland with mild exudates. 
Lung: shows congested alveolar wall with mild thickening and mild emphysematous 
changes.  
Pancreas: shows pancreas with acini and normal islets.  
Heart: shows congestion and mild inflammatory infiltration in between cardiac 
muscle bundles. 
IMPRESSION: NORMAL STUDY 
93.6gTREATED (High dose)10X 
Heart: shows hypertrophic cardiac muscle bundles.  
Spleen: shows lymphoid hyperplasia. 
Liver: shows marked dilatation of sinusoids, degeneration of hepatocytes, necrosis.   
Stomach: shows stomach with superficial erosion and congestion  
Kidney: shows renal tissue with tubular epithelial damage.  
Pancreas: shows normal islet cells. 
Lung: shows congestion, narrowed alveolar space and thickened alveolar  wall. 
IMPRESSION: NORMAL STUDY 
Results:  
 No weight loss, abnormal animal behaviours, metabolic functions [urination, 
lacrimation, defaecation etc.,] and mortality were noted. 
 In necropsy of the animal organs showed normal appearance and weight. 
 All Haematological and biochemical parameters were within normal limits. 
 The stastical report of the Haematological and Biochemical datas did not show 
any significant difference, between the control and test groups.  
 In Histopathological studies, No abnormal findings were observed in the 
organs such as Heart, Liver, Lungs, Kidney and Stomach in X, 5X and 10X 
compared with control group. 
  
 
 
 
 
 
 
 
 
 
DISSCUSSION 
DISCUSSION 
 In this study AVC was subjected to qualitative, quantitative and toxicity 
studies. Quantitative analysis includes ICP OES, HR SEM, FTIR and XRF. And then 
finally both acute and 28 days repeated oral toxicity study was carried out in Wistar 
albino rats as per OECD guidelines. 
 Qualitative analysis of AVC shows the presence of magnesium, mercury, 
chloride, phosphate, ferrous iron and tannic acid. 
     In the Physico Chemical Analysis the pH of AVC was 8.3-8.5. It denotes 
alkalinity. Thus, on oral intake it will not cause any strong alkali or acid like irritation 
to the gastrointestinal tract. The loss on drying at 105ºc was only 0.86% w/w; hence 
the drug will not loose much of its volume on exposure to atmospheric air at room 
temperature. From sieve analysis the size distribution of AVC and the particle 
retained is 54.74% at 75µ  
  HR SEM analysis of AVC reveals the particle size as 50-100nm. The 
particles were homogenously distributed in the chendhuram. And smooth surface of 
the particles enable its easy for absorption in the gastro intestinal tract. Hence the drug 
will have increased bioavailability. (Fig.4.) 
 In ICP-OES study, heavy metals like As, Pb, Cd were found below detection 
limit in unpurified and purified veeram. Mercury, calcium, iron, sodium, 
phosphorous, potassium levels were decreased in its level from unpurified to purified 
veeram and same as seen in Ayam. 
 There was a drastic reduction in the level of mercury in unpurified 
veeram(124.514) to purified Veeram (95.362). Mercury was detected in the finally 
prepared medicine AVC as (3.145). The ferrous compound is drastically reduced from 
652.441 in unpurified ayam to 523.859 in purified form which further decrease in 
AVC as 192.9. This indicates that all heavy metals in AVC were within normal range 
and near to permissible limit. The XRF analysis of AVC all shows heavy metals in 
normal limits. So that AVC is safe for human consumption 
 
FTIR analysis of AVC shows the presence of functional groups amide groups 
carboxylic acids,alkynes, aldehydes, primary amines,aliphatic amines. The aromatic 
compound is seen in purified ayam and lost in the final drug.  
  In Acute toxicity study period there were no abnormal signs developed in 
albino rats at dosage levels of 5mg, 50mg, 300mg and 2000mg/kg b.wt in 24 hrs. No 
mortality was observed in the study period.  
  At the end of Repeated oral toxicity study animals were sacrificed by 
using excessive ether anaesthesia and blood samples were collected then investigated. 
The organs were collected and sent for histopathology study. All the reports were 
statistically calculated. There were no significant changes in, biochemical 
investigations, body weight, food and water intake. There was a marked increase in 
haemoglobin and TRBC in test groups, but compared to control group, it is not 
statistically significant. 
The Histopathological study on the organs such as heart, lungs, kidney, brain 
and liver was normal in control, X, and 5 X groups. In 10 X group, the kidney shows 
renal tissue with focal damage, interstitial inflammatory collection. Glomeruli shows 
epithelial proliferation. Liver shows hepatocyte with mild fatty changes in 5X and 
marked dilatation of sinusoids, degeneration of hepatocytes, necrosis in 10X. Lung 
shows congested alveolar wall with mild thickening and mild emphysematous 
changes. Spleen shows congestion with lymphoid hyperplasia. 
  
 
 
 
 
 
 
SUMMARY 
SUMMARY 
 Siddha system is the ancient traditional system followed in South India mainly in 
Tamilnadu. It incorporates many herbal, mineral and metal based medicines. veeram is 
mentioned under minerals and ayam is mentioned under metals. Ayaveera chenduram is one 
of the notable medicine in the treatment of arthritis, hemeplegia, ulcers and chronic pain 
associated with other degenerative disease. AVC was taken from the literature Anuboga 
Vaithya Navaneetham part I. 
  The raw drug veeram and ayam was procured from country drug shop and 
authenticated at Siddha Central Research Institute. Raw drug was purified and the medicine 
was prepared as mentioned in the Siddha literature.  
 Chemical analysis of unpurified and purified veeram sample indicates the presence of 
mercury, phosphate, iron and magnesium. Analysis of the AVC confirmed the presence of 
mercury, phosphate, iron, magnesium. 
  In physico - chemical analysis of AVC the pH was found to be 8.3 - 8.5 and the loss 
on drying at 105ºC was 0.86% w/w. 
 After HRSEM analysis, the particle size of the AVC was analyzed as 50-100nm 
 In ICP-OES study, heavy metals like As, Pb, Cd were found below detection limit in 
unpurified and purified raw drugs. Mercury, calcium, iron, potassium, phosphorous, sodium 
levels were decreased in its level from unpurified to purified veeram. In ayam, calcium 
magnesium, silicon, phosphate and ferrous compound was seen drastically reduced after 
purification Mercury was detected in minimal level in the finally prepared medicine in AVC 
as (3.145). 
 The toxicological evaluations were conducted as per OECD guidelines for safety 
evaluation of AVC.  
 In Acute toxicity study there were no abnormal signs developed in wistar albino rats 
at fixed dose level within 24 hrs. At the end of the study no mortality and reduction in body 
weight of control and test group animals were observed.            
 In Long term toxicity study there were no significant changes in behavioural signs, 
hematological parameters, biochemical investigation, body weight, food and water intake.  
The lymphocyte count was increased in test groups, but compared with control group it is not 
statistically significant. The histopathological study on the organs such as heart, lungs, 
kidney, and liver was normal in X and 5 X groups compared with control group. In 10 X 
group, the liver shows dilatation of sinusoids, degeneration of hepatocytes and necrosis, lungs 
shows congestion with emphysematous changes and other showed no abnormal histological 
variation. 
  
 
 
 
 
 
 
CONCLUSION 
CONCLUSION 
  As the result of this study, it has been concluded that  
 The decrease in heavy metal content of the prepared medicine when compared to raw 
drug analyzed by sophisticated instrument reveals the potential background of Siddhars 
knowledge in the field of metals, minerals in medicine preparation. Mainly the mercurial 
content of the prepared medicine showed drastic reduction when compared to that of 
unpurified raw drug (124.514 to 3.145). No mortality was observed in preclinical studies, 
hence it is safe to humans and in future clinical studies have conducted to evaluate its 
efficacy. 
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